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ABSTRACT
This thesis examines the development of a transnational advocacy network (TAN) 
around the issue of access to AIDS treatment in the South. Using Karl Polanyi’s notion 
of a ‘double movement’ between economic liberalism and social protection, the AIDS 
TAN is analyzed as a response to the expansion of the market economy to the health care 
sector.
Various policies and processes associated with globalization -  from health 
reforms to the strengthening of international property rights (IPRs) in international 
agreements -  are central in explaining the magnitude taken by the AIDS epidemics in 
developing countries. Viewed as an example of Polanyi’s concept of the double 
movement of social protection against the extension of the free market, the AIDS TAN is 
thus interpreted as reflecting the struggle to define a place for social concerns threatened 
by the increasing emphasis on the self-regulating, or ‘free,’ market. But while economic 
liberalism has remained essentially unchanged, social protection has undergone 
significant transformation, and the characteristics, implications and prospects of this new 
form of advocacy are also discussed.
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PREFACE
Underlying this work is a deep interest in social movements and their capacity to 
effect social change, as well as a desire to come to grip with the current economic and 
social transformations known as ‘globalization.’
My interest in AIDS was first aroused by medical anthropologist Paul Farmer’s 
(1992) insightful analysis of the political economic roots of the Haitian AIDS epidemic. 
It has since been reinforced by sheer bewilderment at the lack of a sense of a common 
humanity - what some have called the ‘differential valuation of human life’ - that makes 
it possible to witness and tacitly accept a tragedy of the scope of the African AIDS 
epidemic because it happens to unknown (one might add ‘black’) ‘others’. Nowhere was 
this made clearer than in the wake of the September I I*  bombing when, faced with five 
anthrax-related deaths, the US quickly reversed its policy of vigorously enforcing patent 
rights, a policy it had maintained in the face of the death of over 20 million Africans from 
AIDS over the previous two decades.^
This might change - has already started to change - however, with the 
development of a transnational advocacy network around the issue of access to AIDS 
treatment in the South. Transnational AIDS advocacy, as I will argue, offers a 
fascinating example of new forms of mobilization addressing the social implications of
Within a matter of days after the first confirmed case of anthrax infection, the Bush 
Administration granted compulsory licenses to other companies for the manufacture 
of generic Cipro. Within weeks, Bayer -  who holds the patent on Cipro - agreed to 
halve the price of Cipro to the government in the interest of public health. The US has 
vigorously and consistently opposed the use of compulsory licenses for the 
manufacture of generic AIDS drugs.
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neoliberal policies. I wish activists’ voices would have been more present in this work; if 
they are not, it is because of time and other external constraints.
Writing on academia and political organizing in lesbian and gay communities, 
Maxine Wolfe (1997) complained that “many academicians write about the work 
activists do, but after the fact and, more often than not, because they use what they want 
to support a theory they already have -  sometimes in bizarre ways.” I honestly tried not 
to do this.
I would like to thank my supervising committee for their availability and 
cooperation in meeting tight deadlines. My sincere thanks to Dr. Paul Bowles for his 
support, shrewd comments and great sense of humour.
INTRODUCTION
“Laissez-faire was planned; planning was not”
- Karl Polanyi (1944)
Analyzing the economic and social transformation of an industrializing society, 
Karl Polanyi (1886-1964) observed a curious paradox: while laissez-faire was the result 
of deliberate state action, ‘planning’ -  that is government intervention in the form of 
social security measures, labour standards, etc. -  arose as a spontaneous protective 
response of society to the disruption caused by the advent of the market economy 
(Polanyi 1957). More than half a century later, this quote applies equally well to the 
current phase of economic liberalization. Indeed, the liberalization of health care over 
the last two decades has given rise to unprecedented levels of social and political 
mobilization, a striking example of which is the development of an AIDS transnational 
advocacy network (AIDS TAN).
The first cases of what came to be known as Acquired Immunodeficiency 
Syndrome (AIDS) appeared in the US in 1981. The Human Immunodeficiency Virus 
(HIV) was rapidly identified as the cause of AIDS (1983), but it was another thirteen 
years before an effective therapy was developed. By 1985, the scope of the epidemic 
became manifest as cases were reported in each region of the world. Throughout the 
1980s and well into the 1990s, the epidemic silently spread, claiming millions of lives.
The discovery, in 1996, of Highly Active Antiretroviral Therapy (HAART) 
offered new hope for people living with HIV/AIDS. As a result of this new treatment, 
the epidemic soon came under control in most industrialized countries. However, the 
contrast between, on the one hand, a small minority of people in industrialized countries 
who has access to AIDS therapy and, on the other, the vast majority of people with AIDS
(PWA) (95 per cent) living in the developing world who have virtually no access to 
AIDS therapy, made unequal access to drugs more visible than ever before. As South 
African Judge Edwin Cameron put it: “We have upside down access to AIDS drugs in 
this world. The drugs are where the disease is not, and the disease is where the drugs are 
not” (Harrington 2000).
In 1997, updated surveillance techniques revealed that the pandemic was far 
worse than previously thought. Based on the most recent data available, 40 million 
people live with HIV/AIDS worldwide. In the year 2001 alone, 5 million were newly 
infected and 3 million died (UNAIDS/WHO 2001). Sub-Saharan Africa is by far the 
most affected region. With 10 percent of the world’s population and only 1 per cent of 
the world's income, it accounts for 70 percent of H3V/AIDS cases and 80 per cent of 
AIDS deaths in the world (Nagarajan 2001).
The international community and national governments were slow to respond to 
the epidemic. This was associated, in the early years of the epidemic, with AIDS’ 
categorization as a ‘gay disease.’ The discovery of heterosexual epidemics in Africa 
prompted a surge of concern, but once it became clear that, thanks to combination 
antiretrovirals (ARVs), the AIDS epidemic could be contained in the industrialized 
world, the third world pandemic lost its urgency in the eyes of the international 
community (Gellman 2000a). Throughout the epidemic, levels of funding have remained 
appallingly low, with no possible comparison with the magnitude of the pandemic (ibid.).
It is in this context of lack of political will, scarce funding and lack of access to 
treatment that we see the development, in the late 1990s, of a transnational advocacy 
network (TAN) around the issue of access to AIDS therapy. TANs include “those actors
working internationally on an issue, who are bound together by shared values, a common 
discourse, and dense exchanges of information and services.” (Keck and Sikkink 1998:2).
Of the many forms of resistance to neoliberal globalization, the campaign around 
access to HIV/AIDS drugs is one of the most interesting but least studied ones. In this 
thesis, I propose to analyze the development of an AIDS TAN as a response to the 
expansion of the market economy to the health sector.
There has recently been a resurgence in interest in Polanyi’s analysis of market 
economies and his ideas have been applied to the contemporary era of the global market. 
Polany’s notion of a ‘double movement’ between the principle of economic liberalism 
and the principle of social protection provides a fruitful conceptual framework: viewed as 
an example of the double movement of social protection against the expansion of the 
free-market, the development of the AIDS TAN is interpreted as reflecting the struggle to 
define a place for social concerns threatened by the increasing emphasis on liberalization 
and the self-regulated or ‘free’ market.
‘Liberalization’ refers broadly to the intensification and acceleration of flows of 
capital, trade and investment over the last two decades, accompanied by privatization and 
the growing power of transnational corporations and international financial institutions 
(IFIs). Much like the nineteenth century economic liberalism described by Polanyi in 
The Great Transformation, the current phase of liberalization is not conceived as a 
natural and inescapable process, but as being propelled by specific interests and an 
ideology - neoliberal globalism -  understood as the norms, institutions, and laws that 
promote global capital accumulation along neo-liberal principles (The Globalism Project 
2001).
As the title - Accessibility crisis in the ‘Age o f access’ - indicates, the issue of 
access to ADDS treatment points to a fundamental paradox: on the one hand, economic 
globalization has been hailed as heralding the ‘age of access,’ where what is traded is no 
longer commodities but access to services (Rifkin 2000)? Yet, as the crisis of access to 
AIDS drugs in the developing world reveals, economic globalization has also 
compounded the problem of access to medicines for a large part of the world’s 
population.
While the principle of economic liberalism - aiming at the establishment of a self­
regulating market, relying on the support of the trading classes (i.e. those engaged in 
commerce and finance) and using largely laissez-faire and free trade as its methods - has 
remained essentially unchanged, the principle of social protection has, in contrast, 
undergone significant transformation. In nineteenth century Britain, it took the shape of a 
regulated economic order under the guidance of the nation-state. The principle of social 
protection as embodied in contemporary TANs, in contrast, operates independently of 
governments, relies on innovative methods (for example symbolic politics and the 
strategic use of information), and its membership cuts across borders and classes.
This thesis aims at getting a better understanding of the dynamics of resistance to 
economic liberalism, of the role of social movements in shaping economic policies, as 
well as of the role, strengths and limits of TANs. The purpose is to examine both the 
extent to which Polanyi's theories are useful in interpreting the global era, and the extent 
to which the AIDS TAN constitutes an example of the double movement.
 ^ In this economy, property still exists, but it is not exchanged. It is kept in the hands of 
producers and accessed by customers as ‘services’ through memberships, licensing 
agreements, etc.
Despite the fact that it represents a significant development, there has been very 
little research on AIDS transnational advocacy to date.^ This is no doubt partly due to its 
newness: although the AIDS activist movement can be traced back to the late 1980s, a 
transnational network only crystallized around the issue of access to treatment over the 
last two years. Moreover, while there is a large literature on economic liberalism and 
social movements, the originality of this study is to look at the dynamic relationship 
between the two. Social movements research most often studies individual social 
movements in isolation, as if they emerged and evolved on their own (Tarrow 1998; 141). 
This thesis, in contrast, focuses on the emergence of an AIDS TAN as a response to the 
liberalization of health care. Indeed, it was Polanyi’s insight that the dialectics of 
movement and countermovement further our understanding of resistance (Mittelman 
1998: 852).
The first chapter sets up the conceptual framework and reviews the literature on 
contemporary social movements. 1 present Polanyi’s theory of the ‘double movement’ 
and show its relevance to understanding contemporary social movements such as the 
AIDS TAN. 1 also introduce New Social Movement (NSM) theory, which developed 
Polanyi’s insight that the classical Marxist framework of analysis had to be broadened 
away from the focus on industrial workers as the only progressive force in society.
In the second chapter, 1 will argue that the magnitude taken by the AIDS epidemic 
in developing countries cannot be understood independently of neoliberal policies and
 ^ As 1 was completing this thesis, a book was published that traces the history of the 
conflict opposing third world countries and NGOs to the pharmaceutical industry 
(Benkimoun 2002a). This work does not focus on AIDS but discuss infectious 
diseases more generally. To my knowledge, there has not been any study of 
transnational AIDS advocacy to date.
processes. Tracing the extension of the market economy to the health-care sector over 
the past two decades, I will assess the impact of neoliberal economic policies on the 
AIDS pandemic and discuss the specific mechanisms by which these policies have 
influenced its development. Of course, the relationship between globalization and AIDS 
is not as straightforward as in the case of Polanyi’s analysis of the social impact of 
industrial capitalism. It is nonetheless clear that policies and processes associated with 
economic globalization, from the liberalization of health services and the collapse of 
public health systems to the strengthening of intellectual property rights (IPRs) in 
international trade agreements, are intricately linked with the development of the AIDS 
pandemic.
Finally, the central part of my thesis examines the AIDS TAN formed around the 
issue of access to AIDS treatment in the South. After briefly discussing the development 
and nature of the AIDS TAN, I will attempt to determine whether it reflects the idea of a 
movement of social protection against the expansion of economic liberalization. I will 
argue that, with the AIDS TAN, we see Polanyi’s principle of social protection at work, 
but in a fundamentally different context. I will thus address what is new about this form 
of advocacy, and discuss some of its implications for the state, identity and citizenship.
While the network has achieved some notable successes in its first two years in 
existence, its success in the medium and long term is open to speculation. Does the 
AIDS TAN pose a genuine challenge to neo-liberal globalization? What are its prospects 
of finding sustainable solutions to the issue of lack of access to medicines in developing 
countries, and for bringing about social change more generally? The conclusion will 
address these questions and seek to determine whether the AIDS TAN poses a genuine
challenge to neoliberalism, or if it is likely to become part of a wider ‘embedded 
neoliberalism.’
CHAPTER ONE
Conceptual Framework & Literature Review
When it was first published -  in 1944 in the United States and a year later in 
England -  The Great Transformation went largely unnoticed. Starting in the 1990s, 
however, The Great Transformation, and the work of Polanyi more generally, aroused 
renewed interest, as witness its translation into over half a dozen languages and the 
growing number of articles making use of Polanyi’s concept of ‘double movement’ 
(Mendell 2001).
In this chapter, I introduce the Polanyian concepts used in this thesis, namely the 
notions of ‘double movement,’ ‘market economy,’ ‘commodification,’ ‘fictitious 
commodities’ and ‘embeddedness.’ I then review contemporary uses of Polanyi’s ideas 
and the debate over ‘embedded liberalism’ in the post-World War U period, a debate that 
has important implications for this analysis. Finally, I assess the significance of 
Polanyi’s contribution to the study of the dynamics of resistance to economic liberalism, 
and explain why the ‘double movement’ offers a useful framework for understanding the 
upsurge of mobilization in the wake of the liberalization of health care. But first, let us 
look at some of the reasons behind the surge of interest in The Great Transformation.
Karl Polanyi and The Great Transformation
In The Great Transformation, Polanyi offers a trenchant critique of the market 
economy. The eloquence of his prose is certainly not foreign to the work’s popularity. 
More to the point, the reason for this renewed interest lies - I would argue - in the 
contemporary resonance of Polanyi’s ideas. Upon reading his account of the dynamics
and implications of the advent of industrial capitalism/ we cannot but be struck by the 
similarities with the most recent phase of economic liberalism. Hence, Polanyi’s insight 
(1957: 140) that “the introduction of free-markets, far from doing away with the need for 
control, regulation, and intervention, enormously increased their range” parallels the 
argument that neoliberalism is “rule-driven” (Jacobson 2001: 168).^ Similarly, Polanyi’s 
(1957: 33) lamenting of the “uncritical reliance on the alleged self-healing virtues of 
unconscious growth,” his discussion of the role of haute finance, and his shrewd critique 
of the liberal ideology ring true to the contemporary reader.
Besides the relevance of his analysis to contemporary developments, another 
reason for the renewed interest in Polanyi’s ideas lies in the concerns underlying his 
account of the rise of industrial capitalism. The Great Transformation is fundamentally 
about the subjugation of social values to the imperative of the market. These concerns 
were somewhat put to rest under post-World-War II welfare capitalism. With the 
acceleration of economic liberalization in the 1980s, and the concomitant erosion of the 
welfare state, they are now re-emerging stronger than ever.
Finally, another reason for the interest in Polanyi’s work is that he offers a non- 
Marxist critique of the market economy and, consequently, did not suffer from the 
general disenchantment with socialist analysis in the wake of the collapse of the Soviet 
Union and socialist regimes.^
Polanyi (1957: 83) dates the institution of industrial capitalism as a social system to 
1834, the year The Poor Laws were introduced.
Jacobson (2001: 168) is referring here to the “increasing global network of legal 
arrangements and ties, arbitration mechanisms, regimes, institutions and the like,” tnis 
‘globalization of law’ being the legal facet of economic globalization.
Polanyi’s relationship to socialism is ambiguous and changed overtime. See 
“Intellectual fad or lasting contribution?” below.
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Economistic fallacy, fictitious commodities and other Polanyian concepts...
The Great Transformation is the story of the rise to prominence of markets in 
capitalist economies and of the reaction of society to the social dislocation it engendered/ 
According to Polanyi, the fundamental change underlying the industrial revolution was 
the establishment of a market economy, or self-regulating system of markets, i.e. an 
economy directed by market prices only (Polanyi 1957: 43). The market economy is said 
to be self-regulating in that it is “a system capable of organizing the whole of economic 
life without outside help or interference” (ibid.).^
Polanyi challenges the liberal claim that the emergence of the free-market was a 
natural development. On the contrary; “the idea of self-regulation,” Polanyi argued, “was 
a complete reversal of the trend of development”: mercantilism “thought of markets in a 
way exactly contrary to market economy” and was “averse to the idea of 
commercializing labor and land -  the precondition of market economy” (ibid.: 68,70).
Far from being an ineluctable development - the natural and logical outcome of 
the spread of markets - the advent of the market economy is seen as a political project 
propelled by definite social forces: “the road to the free-market was opened and kept 
open by an enormous increase in continuous, centrally organized and controlled
For some. The Great Transformation refers to the advent of the market economy; for 
others, to its transformation under the pressure of society. While both interpretations 
are plausible, I personally favour the latter, in which the great transformation refers to 
Polanyi’s prediction of the end of the self-regulating market.
Polanyi distinguishes between laissez-faire and the free-market, two terms that are 
often used interchangeably. Laissez-faire is defined as the ‘freedom of contract’ (for 
workers as well as businessmen), whereas ‘free-markets’ refer to an economic system 
in which all factors of production are commodified. According to Polanyi (1957: 
148), when the principles of laissez-faire were found to conflict with the working of 
the free-market, the latter took precedence and laissez-faire was abandoned in favour 
of various forms of intervention.
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interventionism (ibid.: 140).” Hence Polanyi’s apparently contradictory assertion that 
“laissez-faire was planned” (ibid.: 141). The fact that laissez-faire was the result of 
deliberate state action is evidenced, for example, in the enormous increase in the 
administrative functions of the state.
The Great Transformation is a passionate indictment of economic liberalism:
“Scholars proclaimed at unison that a science had been discovered which put the 
laws governing man’s world beyond any doubt. It was at the behest of these laws 
that compassion was removed from the hearts, and a stoic determination to 
renounce human solidarity in the name of the greatest happiness of the greatest 
number gained the dignity of secular religion (ibid.: 102).”
More specifically, Polanyi undertakes to take apart some of economic liberalism’s key
assumptions. Hence, he challenges economic liberalism’s assertion that humans have an
alleged “natural propensity to barter, truck and exchange one thing for another” (ibid.:
43). Prior to the nineteenth century, Polanyi argues, the economic system was run on
non-economic motives (such as social standing and other social considerations), and
patterns other than the market -  for example reciprocity and redistribution - prevailed
(ibid.: 55).^ Only with the industrial revolution did gain and profit become prime
motives, and the market the overarching ordering principle. The purported ‘natural’
profit-maximising behaviour was in fact the product of a society in which people become
dependent on the market to earn a living (Lâcher 1999a).
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It is interesting to note, in light of Polanyi’s critique of the liberal assumption of the 
naturalness of the market to human society, that some now predict the disappearance 
of commodity markets in the twenty-first century and their replacement by virtual 
networks trading access to services (Rifkin 2000).
Polanyi thus distinguishes between the formal definition of economics as ‘rational, 
economizing behaviour,’ and a substantive definition of economics as ‘want- 
satisfying behaviour’ (Jessop 2001: 213). He referred to the imposition of a market 
frame of reference on non-market societies as the economistic fallacy. One of 
Polanyi’s most important contributions, this distinction gave rise to the substantivist 
and formalist schools in economic anthropology. While the latter holds that market
12
The change from regulated to self-regulating markets demanded “nothing less
than the institutional separation of society into an economic and political sphere”
(Polanyi 1957: 71). This is the crux of the embeddedness thesis advanced by Polanyi.
Whereas in pre-capitalist societies, the economy is submerged in social relationships and
regulated by custom and law, magic and religion, we see a reversal with the advent of the
market economy, whereby society is made to conform to the needs of the market (ibid.:
55). In other words, instead of the economy being embedded in social relations, social
relations became embedded in the economic system (ibid.: 57).
The market economy indeed demanded the commodification of nature (as ‘land’),
humans (as ‘labor’) and money:
“But labor and land are no other than the human beings themselves of which society 
consists and the natural surroundings in which it exists." To include them in the 
market mechanism means to subordinate the substance of society itself to the laws of 
the market” (ibid.: 71).
Stated differently, nature, humans and money are not produced for sale on the market and
therefore are not commodities. Polanyi uses the expression fictitious commodities to
refer to the artificial treatment of nature, humans and money as commodities in a market
economy.
The crucial problem, Polanyi believed, was that the economic advantages of a free 
labour market could not make up for its disruptive impact in terms of social dislocation 
and natural destruction: “human society would have been annihilated but for protective 
countermoves which blunted the action of this self-destructive mechanism” (ibid.: 73).
principles are universal, substantivists maintain that economies organized around the 
market are the exception rather than the rule and that economies have historically 
been embedded in society.
"  Polanyi uses the term habitation to refer to the integrated whole of human life and the 
natural world.
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This is the essence of the famous double movement thesis advanced by Polanyi in The
Great Transformation: “for a century the dynamics of modem society was governed by a
double movement, the market expanded continuously but this movement was met by a
countermovement checking the expansion in definite directions” (ibid.: 130).
The extension of the market organization of genuine commodities was thus
accompanied by its restriction with respect to fictitious ones. Factory legislation, and
social laws were required to protect industrial man from the deleterious consequences of
the commodity fiction with regard to labour. Land laws and agrarian tariffs fulfilled the
same role with regard to the land fiction. Finally, central banking and the monetary
system were introduced to protect manufactures from the money fiction (ibid.: 132).^^
In nineteenth century England, the self-protection of society against the
pernicious effects of a market-controlled economy took the form of social legislation and
of an industrial working class movement (ibid.: 83).^  ^ The self-protection of society,
however, proved incompatible with the functioning of the self-regulating market (ibid.:
129). This is what prompted Polanyi to predict -  somewhat prematurely -  that his age
would see the end of the self-regulating market:
“Though the new protective institutions, such as trade unions and factory laws, were 
adapted, as far as possible, to the requirements of the economic mechanism, they 
nevertheless interfered with its self-regulation and, ultimately, destroyed the system” 
(ibid.: 77).
Other examples of protective mechanisms include factory laws, social insurance, 
municipal trading, health services, public utilities, tariffs, bounties and subsidies, 
cartels and tmsts, and embargoes on the movements of men, goods and payments 
(Polanyi 1957: 144).
Polanyi also discusses two instances of protective social movements, the Owenite 
movement and Chartism.
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What is perhaps more important than the accuracy of his prediction, however, is 
Polanyi’s case that the ultimate responsibility for the problems of the age -  here we have 
to remember that Polanyi was writing in a world devastated by a global economic 
depression and two world wars -  lay with the self-regulating market system itself and 
not, as liberals would have it, with interference with that system (ibid.: 143). Of 
intervention, Polanyi writes that “the accusation of interventionism on the part of liberal 
writers is [...] an empty slogan, implying the denunciation of one and the same set of 
actions, depending on whether they happen to approve of them or not,” an assertion that 
has its counterpart today (Polanyi 1957: 149). The social strains created by the artificial 
and unsustainable separation of the political and economic spheres and the contradictions 
resulting from interventions in the self-regulating market formed the breeding ground 
from which communism, fascism and two world wars eventually emerged. At the heart 
of this upheaval was the failure of the market utopia (ibid.: 218).
Of the contemporary uses o f Polanyi’s ideas
The 1990s saw the publication of several collections of essays on the life and 
work of Polanyi and on the contemporary significance of his thinking, some of them 
under the aegis of the Karl Polanyi Institute o f Political Economy, which has been 
instrumental in disseminating his ideas.''*
The vast majority of articles making reference to Polanyi are written from the 
perspective of international political economy and apply a Polanyian conceptual 
framework to the analysis of post-World War II developments in domestic and
See McRobbie and Polanyi (2000), Mendell and Salee (1991) and Polanyi-Levitt 
(1990).
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international politics and in the world economy.*^ The dominant interpretation among 
critical international theorists is that the regulated markets and interventionist states of the 
post-World War II period realized Polanyi’s vision of a re-embedded e c o n o m y . A s  we 
will see below, this interpretation has however been challenged. Applied to the more 
recent phase of economic liberalization, the concept of double movement has been used 
in general terms to assess whether neoliberal globalization is likely to produce a second 
great transformation.^^
Other authors, following Ruggie (1983), have drawn the implications of Polanyi’s 
analysis for the contemporary financial order. Polanyi’s discussion of the role of haute 
finance is indeed particularly appealing, the central role attributed to the financial 
architecture in the nineteenth century in stabilizing the international political economy 
and in imposing discipline on domestic politics having its counterpart in the 
contemporary global financial order. Harmes (2001) uses the concept of double 
movement to explain institutional behaviour and currency crises, while Helleiner (1995) 
uses Polanyi’s insight to argue that financial globalization is the result of political choices 
and state decisions (and not the product of technological and market development), and to 
question its durability.
Polanyi’s analysis of embeddedness and commodification has also been extended 
to the current phase of economic liberalization. Schaniel and Neale (1999), for example, 
apply the concept of commodification to socioeconomic change in third world societies.
See, for example, Birchfield (1999), Gill (1995), Jessop (2001) and Lâcher (1999a). 
The most well-known supporter of this line of interpretation is Ruggie (1983).
See Bernard (1997), Helleiner (1995) and Zincone and Agnew (2002).
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and Altvater and Mahnkopf (1997) argue that we are in the midst of a ‘second stage of 
disembedding’ or ‘global’ disembedding.
Among the surge of publications, two articles -  by Barham (1997) and Mittelman 
(1998) - stand out for moving beyond a general discussion and looking at specific 
instances of contemporary resistance to economic liberalism. Barham and Mittelman use 
a Polanyian approach to discuss, respectively, environmental activism and the movement 
for sustainable agriculture. Both believe that approaching resistance in a Polanyian 
manner - i.e. as the expression of social protection - is extremely valuable, and conclude 
that these social movements provide some support for Polanyi’s thesis of a double 
movement of social protection.
Polanyi in the age o f Keynes: has the double movement stood the test o f time?
In an often-quoted article entitled “International regimes, transactions, and 
change: embedded liberalism in the postwar economic order,” Ruggie (1983) 
characterizes the post-World War II international economic order as a form of embedded 
liberalism, a multilateral economic order predicated upon domestic intervention (Ruggie 
1983: 209). In this view, embedded liberalism and its domestic counterpart, welfare 
capitalism, point to a fundamental change in the distribution of power between political 
‘authority’ and the ‘market,’ and the reassertion of the former over the latter. Ruggie 
thus concludes that Polanyi’s prediction that his age would see the end of the self­
regulating market has been realized.
This interpretation, however, has been criticized as distorting the meaning given 
to embeddedness by Polanyi, giving rise to what is perhaps the most interesting debate
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surrounding The Great Transformation}^ This controversy over the meaning of 
(re)embeddedness and whether or not it was achieved under welfare capitalism has direct 
relevance for assessing whether the AIDS TAN represents a genuine challenge for the 
market economy, or if it is likely to lead to a form of ‘embedded neoliberalism’ (a 
question that will be taken up in the conclusion).
My view is that the second interpretation is more in line with Polanyi’s 
conception of embeddedness. According to Polanyi (1957: 251), a re-embedded 
economy is one in which “the economic system ceases to lay down the law to society,” 
and in which “the primacy over that system is secured”. Re-embedding thus demands the 
decommodification of labour, i.e. “to take labor out of the market” (ibid.: 251).
These conditions were clearly not met under welfare capitalism as it developed in 
North America and Western Europe. A case can be made that labour underwent some 
relative decommodification during this period, through measures such as labour standards 
and social legislation. However, as Lâcher (1999a) points out, this partial 
decommodification of labour was accompanied by the extension of the scope of 
commodification to previously unaffected social realms, such as health and social
19services.
More fundamentally, protectionism was not seen by Polanyi as a long-term 
solution to the problems created by the commodification of human labour and nature. On 
the contrary, Polanyi discusses at length in The Great Transformation how fascism, 
communism and two world wars resulted from the interference of protective measures 
with the working of the free-market. In contrast to liberal economists, Polanyi did not
18 For a more exhaustive discussion, see Bernard (1997) and Lâcher (1999a).
The issue of commodification will be discussed in the next chapter.
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see the ultimate cause of these events in protectionism itself, but rather in the attempt to 
establish a self-regulating market that gave rise to the countermovement in the first place 
(Lâcher 1 9 9 9 a ) . T h i s  is because protectionist measures, to the extent that they left 
intact the primacy of the market mechanism, did not resolve the contradiction between 
economy and society, but merely exacerbated it.
Lâcher (1999a) goes further and argues that “the welfare state and the Pax 
Americana must be seen as the negation of all that Polanyi had hoped and wrote for.” 
Under embedded liberalism, market society was taken as a given; in fact, “the social and 
international order established by the New Deal was based not on a re-embedding of the 
economy, but on the further universalization of capitalism” (Lâcher 1999a).
Intellectual fad or lasting contribution?: the double movement and resistance to 
economic liberalism
The Great Transformation is in keeping with a long tradition of writings on 
resistance to the disraptive social impact of the spread of the market system. The 
industrial revolution, and the development of capitalism more generally, have also been 
the object of extensive analysis, foremost of which is that of Marx. In this section, I will 
clarify differences between the Polanyian and Marxist analyses, point to some criticisms 
of Polanyi’s work, but also explain why it represents a valuable conceptual framework.
Polanyi’s relationship to socialism is ambiguous, and changed over time. While 
he never identified himself as Marxist -  and at some points explicitly rejected Marxism -
^  Protectionist measures contributed to precipitate the crisis by interfering with the 
working of the free-market, and were thus seen as leading the way to a real re­
embedding of the economy. On this count, events did not prove Polanyi right.
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Marx undeniably exerted an important influence on his thinking/^ Hence, Polanyi’s 
analysis of the commodification process inherent to the institution of the market economy 
has a parallel in Marx’s discussion of commodity fetishism. While they use different 
expressions - fictitious commodities versus commodity fetishism; disembeddedness 
versus alienation -  there are important points of contact between their respective 
analyses. Although Polanyi’s analysis is not as exhaustive as Marx’s, his description of 
the implications of the commodification of labour -  “to annihilate all organic forms of 
existence and to replace them by a different type of organization, an atomistic and 
individualistic one” -  recalls Marx’s depiction of the alienation of man from work under 
industrial capitalism (Polanyi 1957: 163).
What Polanyi clearly rejects, however, is Marxism’s materialist determinism. As 
he writes, “never has there been such an absurd superstition as the belief that the history 
of man is governed by laws which are independent of his will and action.” This is also 
revealed in Polanyi’s conception of history and human agency. History is not conceived 
in an unidirectional and deterministic fashion; in fact, the establishment of a market 
economy is seen as a reversal of the trend of development under the pressure of powerful 
social interests, mostly those of the trading classes. Polanyi’s account also places special 
emphasis on human institutions and interests: “what we are searching for is not a 
convincing sequence of events, but an explanation of their trend in terms of human 
institutions” (Polanyi 1957: 4).
According to his daughter, Kari Polanyi-Levitt, Polanyi “although not a Marxist, was 
much less a social democrat” (McRobbie and Polanyi 2000: 119). Others have 
argued that what Polanyi sought was a form of industrial democracy, where control 
over production would no longer be driven by the quest for profit, but would be 
subject to the self-determination of society (Lâcher 1999a).
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What Polanyi guards against -  and this is an important distinction -  is not the
market per se, but its elevation, with the advent of the market society, to the status of
organizing principle of society:
“No society could, naturally, live any length of time unless it possessed an economy 
of some sort; but previously to our time no economy has ever existed that, even in 
principle, was controlled by markets. In spite of the chorus of academic institutions so 
persistent in the nineteenth century, gain and profit made on exchange never before 
played an important role in human economy. Though the institution of the market was 
fairly common since the later Stone Age, its role was no more than incidental to 
economic life” (ibid.: 43).
Polanyi only makes a brief reference to socialism toward the end of The Great
Transformation: like fascism, socialism was “rooted in a market economy that refuses to
function” but, unlike fascism, its reform of the market economy was not achieved at the
price of the extirpation of all democratic institutions (ibid.: 239). Socialism is “the
tendency inherent in an industrial civilization to transcend the self-regulating market by
consciously subordinating it to a democratic society” and thus -  at least in principle -
fulfilled the purpose of social protection (ibid.: 234). Despite this overall positive
appraisal. The Great Transformation cannot possibly be interpreted as a rallying cry to
socialism.
In contrast to Marx, Polanyi rejects a rigid class analysis, which he believed could
not capture the multiple ways in which the market economy affects different segments of
society (Barham 1997). While he recognizes the importance of classes -  he argues, for
example, that the conflict of class forces played a decisive role in the final phase of the
fall of the market economy - Polanyi generally favours a social over a class analysis:
“[...] no single groups or classes were the source of the so-called collectivist 
movement, though the outcome was decisively influenced by the character of the 
class interests involved. Ultimately, what made things happen were the interests of 
society as a whole, though their defense fell primarily to one section of the population
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in preference to another. It appears reasonable to group our account of the protective 
movement not around class interests but around the social substances imperilled by 
the market.” (Polanyi 1957; 162).
Polanyi’s emphasis on a social rather than class analysis should not be interpreted as a
rejection of ‘class’ as a relevant category of analysis -  Polanyi stresses, for example, that
the emphasis on class is important and “shaped the whole social history of the nineteenth
century” -  but rather as an attempt to move away from Marxism’s exclusive focus on the
working-class as the ‘true’ agent of social change (ibid.; 133). Social protection, Polanyi
sought to demonstrate, took different forms and arose among various segments of the
population.
Polanyi, however, does not specify what he means by ‘social substances,’ and he 
has been rightly criticized for using ‘society’ in a rather broad and ambiguous way 
(Birchfield 1999; 39). Bernard (1997; 82) also raises what he calls the ‘problem of 
agency’ in Polanyi’s work, by which he refers to how, while Polanyi generally 
emphasizes the role of powerful social forces in promoting economic liberalism, a certain 
technological determinism marks his account of the origins of the industrial revolution. It 
is true that Polanyi (1957; 74-76) confers a central role to the invention of elaborate and 
specific machinery in ushering in the industrial factory and the market system. A more 
generous reading of Polanyi, however, would also recognize that he argues that the new 
productive organization was introduced by specific social forces (the merchants), and that 
the transition to the market system was operated by “completely changing the 
relationship of the merchant to production” (ibid.; 75).
What seems to be a more problematic aspect of agency in Polanyi’s writings is the 
tendency to naturalize social protection. The countermovement is indeed described as a
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‘spontaneous reaction,’ an automatic response to the deleterious effects of market forces 
(ibid.: 149, 184). Ironically, Polanyi does with social protection what he blames 
economic liberalism for doing with respect to the development of the market system.
Finally, it is questionable whether the economy can be said to be “disembedded” 
in any society. Polanyi himself seems ambivalent on this issue: hence, he writes that “no 
market economy separated from the political sphere is possible, yet it was such a 
construction which underlay classical economics” (ibid.: 196).
Polanyi’s criticism of economic liberalism is thus not without precedent. Nor is it 
exempt of all problems. Despite these pertinent, but overall minor, critiques. The Great 
Transformation offers a useful conceptual framework for looking at contemporary global 
social and economic processes.
Some have indeed hailed The Great Transformation as a new “paradigm for a 
post-Marxist critical theory” (Schroyer 1991: 66). The importance of Polanyi’s work is 
that it offers an alternative to the discredited functionalism of the dominant Marxist 
interpretations while at the same time incorporating some of its most important insights. 
Polanyi’s contribution is twofold, and follows from the methodology used, which 
combines a long-run perspective - looking back at the nineteenth century and early 
twentieth century from the standpoint of the 1940s - with a multidisciplinary approach 
(Hill and von Ende 1994).
The liberalization of health care being traced to the early 1980s (see chapter two), 
the present study does not benefit from the same hindsight as Polanyi’s work Applying a 
long-term perspective, however, shifts attention away from the short-term economic and 
political consequences of globalization -  the focus of most studies of globalization -
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towards its longer-term implications (Zincone and Agnew 2000: 5). The 
multidisciplinary approach adopted by Polanyi also proves fruitful. It is the insights 
gained from economic anthropology that allow Polanyi to challenge some of economic 
liberalism’s most deeply-held premises. The approach adopted here is also 
multidisciplinary, combining insights from international studies with those from medical 
anthropology and sociology. Such an approach is warranted in attempting to understand 
a process as complex and multi-faceted as globalization.
Along with Polanyi’s argument regarding the emergence of countermovements in 
response to economic liberalism, the fundamental Polanyian insights that inform this 
study include his conception of human nature, the view of economic liberalism as a 
political project, and his analysis of the implications of commodification for human 
society and nature.
Polanyi in the age ofHayek: the second great transformation ?
Gill (1995) has recently argued that developments in world politics in the 1990s 
point to a second ‘great transformation.’ Zincone and Agnew (2002: 5) concur and add 
that economic globalization is “on a par in its potential impact with the transition to 
market society” discussed by Polanyi. This transformation in the forces of production, 
they believe, is accompanied by “a potential positive transformation in the geographical 
organization of political rights and citizenship,” comparable in scope, and in its effects, to 
the first transformation of society under the pressure of market society (Zincone and 
Agnew 2002: 5).^ While this may be intuitively appealing, it is important to ask what 
would constitute a refutation of Polanyi’s theory, all the more so since, as Waller and
This will be further explored in chapter two.
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Jennings (1991) point out, the double movement thesis can easily become a tautological 
argument, whereby “whatever does not further the market reforms it.”
Here I will test the double movement against Polanyi’s own criteria of what 
defines the double movement, i.e. that the principles of economic liberalism and social 
protection (1) set themselves specific institutional aims, (2) have the support of definite 
social forces and (3) use their own distinctive methods (1957: 132). Polanyi’s theory 
would thus be refuted if either principle did not meet these three criteria with regard to 
aims, membership and methods. Hence, contemporary economic liberalism should be 
aimed at the establishment of a self-regulating market, rely on the support of the trading 
classes, and use laissez-faire and free trade as its methods. The argument is less clear-cut 
when it comes to social protection. According to Polanyi, the latter is aimed at the 
conservation of man, nature and productive organization; it relies on the support of those 
most immediately affected by the deleterious action of the market; and it uses different 
instruments of intervention, such as protective legislation, as its methods.
But what is more important, and challenging, than identifying the principles of 
economic liberalism and social protection is to understand the dynamics between the two. 
One way to get at this idea of the double movement is to seek to uncover the motives of 
activists involved in these countermovements. Waller and Jennings (1991) argue that -  
in its most ‘reasonable’ understanding -  the thesis of the double movement can be 
interpreted as meaning that:
“[...] market economies are not as fair and equitable as formalist theory would 
have us believe, and that socially undesirable outcomes that are not supposed to arise 
do. Frequently, these difficulties give rise to a social response that is not typically a 
rejection of market society, but rather an effort toward reform of the most egregious 
excesses of individualistic society, often undertaken in the name of the very social
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values of fairness, opportunity, and equality that individualistic values both glorify 
and countervene.”
To this ‘reformist’ interpretation of the double movement, one can oppose a more 
radical reading whereby the protective social response must not simply seek to strike a 
balance between “the ‘laws’ of the market and the needs of human communities and the 
environment,” but challenge the primacy of the market. In order to qualify as an 
illustration of the double movement, activists involved in transnational AIDS advocacy 
should thus seek to re-embed the economy in political institutions through the de­
commodification of health.
The New Social Movements
Bastos (1999), Epstein (1995) and Gamson (1989) make a strong case for 
understanding the AIDS movement as a New Social Movement (NSM). The expression 
‘new social movement’ was first introduced by the sociologist Melucci in the 1970s to 
refer to post-industrial social movements, which he argued differed from industrial 
working-class movements (Pichardo 1997). Examples of NSMs include youth and 
counter-cultural movements, alternative economic and cooperative organizations, black 
civil rights, and gay and lesbian movements (Adam 1993).
NSM theory developed in response to Marxism’s failure to account for 
contemporary (post-1965) social movements such as the feminist, peace or ecological 
movements. The latter indeed did not fit the Marxist conviction that any significant 
social change would come from a working-class movement aimed at seizing state power. 
NSMs thus marked a shift away from the state and capital towards the politics of culture 
and identity. As Gorz puts it, the aim of participants in NSMs is “not to seize power in
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order to build a new world, but to regain power over their own lives by disengaging from 
the market rationality of productivism” (Pichardo 1997).
NSMs are said to represent new forms of resistance to the commodification of 
social life, to bureaucratization and to the impact of mass media on collective identities, 
in a context where the impact of the state and the economy on society has become 
profound and dispersed, social control is deepening, and the political and economic 
institutions are no longer able to compensate for their own shortcomings (Pichardo 1997: 
420). Touraine’s (2000) argument, like Polanyi, is rooted in the view that our time is 
characterized by the divorce between culture and economy. While this is not new, 
Touraine (1998) argues that “we are experiencing a deeper and more fundamental 
division of the world than that known by nineteenth-century society.” In this context, 
NSMs would represent a response to, in Habermas’ words, the “colonization of the 
lifeworld” by the state and capitalist economy (Strydom 1990).
NSM theory can be conceived as an extension of Polanyi’s theory of 
countermovements of social protection against the extension of the market economy, a 
new form of resistance to the commodification of social life. NSMs are indeed 
concerned with the self-defense of society against the state and the market-economy 
(Pichardo 1997: 420).
NSMs have been described as “rooted in micro organizations [...] and cultural 
projects,” as characterized by “short-term and reversible commitment, multiple 
leadership, temporary and ad hoc organizational structures,’ and as being “context 
sensitive and egalitarian” (Adam 1993). NSMs generally have a practical orientation, 
working from below through ‘living social change’ (Adam 1993).
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Ideologically, NSMs question the materialistic orientation of industrial societies, 
and are concerned with the quality of life rather than with economic redistribution. Their 
most distinctive feature is the emphasis on identity, and its self-reflexive character 
(Pichardo 1997: 414). Although “there is no truly distinctive tactical style, NSMs 
generally favour ‘disruptive politics’ and the mobilization of public opinion over 
traditional politics. Their organizational style tends to be ‘open, decentralized and non- 
hierarchical,’ although this is avowedly more an ideal type than a reflection of reality. 
Participants in NSMs are drawn predominantly from the ‘new middle-class,’ or, 
alternatively, are bound by common values rather than by ethnic, religious or class-based 
affiliations (Pichardo 1997: 417).
NSMs’ claims to newness have been challenged on all these counts.^ Without 
entering this debate, let me mention three critiques raised to NSM theory in relation to 
AIDS activism. Firstly, this approach portrays NSMs as essentially defensive, while they 
are in many ways proactive and innovative. Secondly, the claim that NSMs are primarily 
middle-class does not hold in the face of the poverty of many PWAs involved in the 
AIDS movement. Finally, NSM theory’s emphasis on cultural politics and identity- 
oriented activities tends to underestimate the extent to which NSMs, although not 
primarily economic movements, address the political economy (Adam 1997: 30).
As Pichardo (1997: 417) notes, NSMs’ most striking feature is perhaps their 
heterogeneity. However, the widespread adoption of the concept seems to confirm NSM 
theorists’ insight that there is indeed something fundamentally new about contemporary 
social movements. There is a consensus on at least two characteristics of NSMs: the fact
23 See D’Anieri et Ernst (1990) and Pichardo (1997).
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that they draw support from the non-traditional (i.e. working class) sectors, and are 
centred on issues of identity, rights and autonomy.
Transnational advocacy networks (TANs) and the AIDS TAN
Keck and Sikkink’s study of TANs (1998) represents a breakthrough in the 
political science literature on contemporary social movements. Indeed, most social 
movements research was until recently grounded in the assumption that social 
movements operate within state boundaries (McCarthy 1997: 243). According to Keck 
and Sikkink (1998: x) the reason why advocacy networks have been generally ignored by 
political scientists is that they are not powerful in the classic sense of the term, i.e. in 
political, economic or military terms.^ While some researchers have recently started to 
study transnational social movements (TSMs),^ the originality of Activists Beyond 
Borders is that the emphasis is on networks rather than individual organizations. 
Although Keck and Sikkink make no explicit mention of NSM theory in their study of 
TANs, their analysis incorporates many of its insights, as evidenced in the emphasis on 
symbolic politics, on the centrality of information, and on the role of norms and values.
Keck and Sikkink discuss three examples of TANs, namely, the human rights 
advocacy network, the environmental advocacy network and the transnational network on 
violence against women. I am not aware of the concept of TAN being used with reference 
to AIDS advocacy, but the AIDS TAN undoubtedly meets the criteria set by Keck and
^  As we will see, however, and the AIDS TAN is a an excellent illustration of this, 
advocacy networks can, through their strategic use of information, bring about change 
by reframing international debates (Keck and Sikkink 1998: x).
See, for example, Smith (1997).
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Sikkink/^ I situate the transformation of the AIDS movement into a TAN roughly at the 
beginning of the year 2000, when the issue of access to AIDS treatment in the South was 
first propelled to the forefront of the international scene. This marks a turning point 
since, for the first time, the idea that the fight against AIDS in developing countries 
should focus on prevention (as opposed to treatment) was called into question.
Transnational AIDS advocacy shares many of the characteristics of NSMs. 
Firstly, it is fundamentally concerned with the quality of life. A reaction against the 
worst excesses of economic liberalism, it aims at limiting the expansion of commodity 
relations to the sphere of health. Secondly, while tactics and forms of organization in the 
network are as diverse as the organizations that participate in it, many have adopted -  the 
Activist Coalition To Unleash Power (ACT UP)’s staged demonstration are an excellent 
example of this -  the symbolic politics characteristic of NSMs. Finally, participants in 
the AIDS advocacy network are not brought together by their structural location in 
society but by their common concern over social and health issues.
^  See chapter three.
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Why Study the Transnational AIDS Advocacy Network?
The development of a network of activists working around the issue of access to 
ADDS treatment in the South no doubt represents a significant development. The ADDS 
TAN has achieved impressive results in terms of external recognition, level of 
organization and effectiveness. Despite its significance, there is little research to date on 
transnational ADDS advocacy; mostly, I would suggest, because of its newness.
Several observers have deplored the loss of historical documentation that 
characterizes ADDS activism (Brown 1997: 27). The problem is not as acute today as it 
was for the first generation of ADDS activists (i.e. prior to the development of tri-therapy 
in 1996), whose ranks were decimated by early and rapid deaths. Nevertheless, it 
remains true that ADDS activism is marred by a lack of historical documentation. One 
objective of this thesis is thus to document the development and nature of this new form 
of advocacy.
Mittelman (1998: 851) notes that “few scholars (with notable exceptions) have 
attempted to theorize the connections between social movements and world politics.” 
Combining the work of Keck and Sikkink on TANs with Polanyi’s concept of double 
movement offers some interesting insights into this relationship. Applying a Polanyian 
approach indeed raises some crucial questions such as, ‘in today’s world, what does it 
mean to ‘re-embed’ economy in society?’
The concept of double movement, however, is not used uncritically, and a 
secondary objective of this study is to assess the relevance of Polanyi’s concept of double 
movement to the understanding of contemporary developments in international politics 
and the world economy. While Polanyi’s work has received growing attention over the
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last decade, there have been few attempts to examine its relevance in the context of 
specific social movements.^
The purpose of this thesis is thus dual, aiming both at examining the extent to 
which Polanyi's theories are useful in interpreting the global era, and the extent to which 
the AIDS TAN constitutes an example of the double movement.
This thesis is thus fundamentally about forms of resistance to economic 
liberalism. What constitutes resistance to neoliberal globalization? Does resistance de- 
legitimize the dominant neoliberal model or does it merely seek to alleviate its worst 
excesses? But first, let us look at how neoliberal globalism -  the late twentieth century 
counterpart to Polanyi’s nineteenth century economic liberalism -  has penetrated into the 
heart of human communities through the commodification of health.
For exceptions, see Barham (1997) on social movements for sustainable agriculture in 
France, and Mittelman (1998) on globalisation and environmental resistance politics.
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CHAPTER TWO
Neoliberal Globalization and AIDS
This chapter examines the implications of neoliberal policies for global health by 
looking at the impact of economic liberalism on the development of the AIDS pandemic. 
Since the double movement is conceived as a social challenge to the commodification of 
society, it is necessary to establish the complex and multiple ways in which neoliberal 
globalization is intertwined with the unfolding of AIDS.
The first section briefly overviews the history of the AIDS pandemic and the issue 
of access to treatment. It gives some figures on the AIDS pandemic and its socio­
economic impact, an impact comparable, I will argue, to the suffering and social 
dislocation wrought upon society in the wake of the industrial revolution.
The next section introduces the context of liberalization and globalization. I will 
discuss briefly what is meant by neoliberal globalism and neoliberal globalization, and 
present those features most relevant to understanding the liberalization of health care. I 
will then discuss in more detail the issue of commodification and its extension to the 
health-care sector over the last two decades.
Finally, the central part of this chapter examines how some of the changes 
associated with globalization -  new forms of transnational social inequality, shifts in 
power at the international level, Structural Adjustment Programmes (SAPs), the 
transnational concentration of capital and the strengthening of IPRs in international 
agreements -  are intricately linked with the development of the AIDS pandemic.
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The AIDS Pandemic: an Overview 
AIDS epidemiology
The first cases of AIDS were identified in 1981, and it rapidly became clear that 
what had first appeared as a series of isolated cases was in fact a worldwide pandemic. 
However, a number of factors -  for example the lack of monitoring systems and the 
covering up of epidemics for political and economic reasons -  ensured that the full extent 
of the pandemic remained unknown well into the 1990s. In 1991, it was estimated that 
there were between 5 and 7 million cases of infections worldwide. As improved 
surveillance techniques soon revealed, this was a gross under-estimation : by 1997, fully 
30 million people lived with HTV/AEDS worldwide, and there were 16,000 new infections 
each day. Based on the most recent data available,^^ 40 million people live with 
HlV/AlDS worldwide. In the year 2001 alone, 5 million were newly infected and 3 
million died.
Sub-Saharan Africa is by far the most affected region. With 10 per cent of the 
world’s population and only one per cent of the world's income, it accounts for 70 per 
cent of HTV/AIDS cases and 80 per cent of AIDS deaths in the world (Nagarajan 2001). 
Some of the worst-affected countries, such as Botswana, have adult HIV prevalence of 
over 35 per cent. In Sub-Saharan Africa, rates of HIV infection in women have 
surpassed those of men, with women now representing 58% of all adult infections in the 
region (UNAIDS 2002d).
Unless stated otherwise, data in this section are taken from the most recent AIDS 
Epidemic Update, co-published by UNAIDS and WHO. Geneva: UN AIDS/WHO. 
December 2001.
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Eastern Europe and Asia are also cause for concern. Eastern Europe has the 
fastest growing epidemic in the world. As for South East Asia, national prevalence rates 
are low, but localized epidemics in different areas raise a serious threat of generalized 
epidemic in the most populous regions of the world.
Even more alarming is the fact that the epidemic shows no sign of slowing down. 
A new UNAIDS report warns that, contrary to what was previously believed, the AIDS 
epidemic is still in its early phase and is not levelling off in the worst affected countries 
(UNAIDS 2002b; 2002c). UNAIDS predicts that, in the absence of drastically expanded 
prevention and treatment, an astonishing 68 million people will die of AIDS in the next 
two decades.
The epidemic is characterized by distinct patterns in industrialized and developing 
countries. In high-income countries, AIDS was until recently confined largely to the gay 
community and injecting drug users, with homosexual transmission being the dominant 
mode of transmission. In developing countries, in contrast, heterosexual transmission has 
been the dominant mode of transmission since the beginning. This, however, could 
change in the future, as there is now evidence that HTV is making inroads among the poor 
in high-income countries.H eterosexual transmission now accounts for a larger share of 
new infections in high-income countries, and the rate of infection among women is on the 
rise (UNAIDS 2002c).
In the US, African-Americans, who make up 13 per cent of the population, account 
for an estimated 54 per cent of new infections in 2000 (UNAIDS 2002c: 40).
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The international response
AIDS has hardly been a priority, as revealed by continual underfunding of AIDS 
programmes. Throughout the 1990s, US funds devoted to AIDS control overseas 
stagnated around $124.5 million, just over half of what Americans pay annually for 
baldness therapy (Gellman 2000a). According to Gellman, the US Agency for 
International Development (USAID) focused much of its energy during this period to 
disengaging itself from mandatory funding of AIDS programmes. As recently as 1999, 
funds devoted to fight AIDS by the West totaled $800 million (Boseley 2002).
Moreover, the distribution of funding does not match the worldwide distribution 
of AIDS cases: in the mid-1990s, only 2.8 per cent of global expenditures for HIV 
prevention went to sub-Saharan Africa, which then accounted for two-thirds of the 
world’s HTV infections (Lurie 1995).
The first substantial increase took place in 2000, when the US acknowledged 
AIDS as a ‘security threat’ and increased its support for international AIDS programmes 
by about $100 million (Harrington 2000). Today, the US spends $1.1 billion on 
international AIDS programmes (Brown 2002). Worldwide, about $2.8 billion is spent 
from all sources to fight AIDS in low- and middle-income countries (ibid.).^°
AIDS treatment
The first therapy for AIDS (AZT) was approved for use in the US in 1987. In the 
following years, a number of antiretroviral drugs (ARVs)^^ were developed, but it was 
only in 1996 that an effective therapy was discovered. Highly Active Antiretroviral
To give a measure of what this represents, the war in Afghanistan, according to 
Clinton, costs $1 billion a month; see www.nat.org.uk.
31 Drugs used to treat HIV/AIDS, which stop the virus from replicating.
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Therapy (HAART) -  commonly known as ‘combination therapy’ (or simply tri-therapy) 
-  uses a combination of drugs, usually one protease inhibitor or non-nucleoside combined 
with two other drugs. Although they do not cure HTV/AIDS, these drugs stop the virus 
from replicating and thus prolong life and improve patients’ quality of life.
Following the introduction of ARV therapy in 1996, the epidemic rapidly came 
under control in industrialized countries. Between 1996 and 1997, deaths attributed to 
AIDS fell by 42 per cent in the US. In developing countries, however, the exorbitant 
price charged by drug companies - $10,000 per year^^ -  kept therapy out of reach of the 
vast majority of the world’s population, and the epidemic continued unabated. The 
growing gap between the incidence of HTV/AIDS in the first and third worlds led some to 
speak of a ‘two-speed epidemie’.
According to the UNAIDS (2002b), only 230,000 people out of 6 million people 
in the developing world in need of ARV therapy -  i.e. less than 4 per cent - have access 
to treatment. Even this figure is somewhat misleading in that one country, Brazil, 
accounts for an overwhelming proportion of PWAs who have access to ARVs in 
developing countries.^ In high-income countries, where an estimated 500,000 people 
receive ARVs, 25,000 people died of AIDS in 2001. In Africa, in contrast, where only
In a situation where people were desperate for an AIDS cure, Glaxo Wellcome could 
afford to charge an exorbitant $10,000 per year for the first ADDS drug (AZT, first 
introduced in 1987) (Scherer 1993: 97). Pricing in the pharmaceutical industry, it 
should be noted, is not directly subjected to the laws of the market.
An explanation for the development of a ‘two-speed’ epidemic will be offered in 
chapter two.
Brazil is one of the few developing countries to provide free ARVs to PWAs. In 
2000, 87,500 Brazilians received ADDS medications under the national ADDS 
programme.
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30,000 of the 28.5 million people infected -  i.e. 0.001 per cent - receive ARVs, AIDS 
killed 2.2 million people.
Socio-economic impact o f the epidemic
“The essence of purely economic progress [...] is to achieve economic improvement at
the price of social dislocation” 
- Polanyi (1957: 34)
I will not dwell on the socio-economic impact of the AIDS pandemic since it is 
widely recognized and abundantly d o c u m e n te d .A  few statistics should suffice to give 
a sense of the extent of suffering and social dislocation inflicted upon societies by what is 
now acknowledged as the worst plague ever faced by humankind.
It is difficult to comprehend the scope of the human tragedy wrought by AIDS. 
mV/AIDS has already caused a spectacular reversal of earlier gains in development, and 
the future of several African nations, on the verge of collapse under the weight of the 
socio-economic consequences of the HTV/AIDS epidemic, is seriously compromised.
A number of sub-Saharan countries have already experienced a sharp drop in life 
expectancy as a result of the HTV/AIDS epidemic. In Botswana, for example, AIDS has 
caused a 26-year drop in life expectancy, from 62 to 36 years. According to a World 
Health Organization (WHO) ranking of countries based on the healthy life expectancy 
(the Disability Adjusted Life Expectancy, or DALE), the ten countries at the bottom (all 
in Sub-Saharan Africa) have below 35 years of healthy life expectancy ranging from 25.9 
years (Sierra Leone) to 33.5 years (Ethiopia) (Nagarajan 2001).
Mann and Tarantola (1996); UNAIDS (2002a 2002b 2002c); UNAIDS/WHO (2001); 
WB (1997).
Unless stated otherwise, data in this section are taken from the most recent AIDS 
Epidemic Update (December 2001) copublished by UNAIDS and the WHO 
(UNAIDS/WHO 2001).
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It is estimated that by 2010, per capita GDP in some of the hardest hit countries 
may fall by 8 per cent and per capita consumption may fall even further. A recent Food 
and Agriculture Organization (FAQ) report reveals the tragic effects of AIDS on the 
agricultural labour force. In the past decade, 7 millions rural workers died of AIDS- 
related diseases in sub-Saharan Africa, and an additional 16 million are expected to die in 
the next two decades. Consequently, the labour force will be reduced by an dramatic 25 
per cent in the most affected countries by 2020 (Nagarajan 2001). This raises the dire 
prospect of widespread food shortages and hunger.
The epidemic is also exacting a high toll on professionals. In some countries, 
already burdened health-care systems are losing up to a quarter of their personnel to 
AIDS. By the late 1990s, AIDS deaths had forced the closure of more than one hundred 
educational establishments in the Central African Republic. In South Africa, some firms 
hire three people for one job, to take into account the likelihood of early death.
The epidemic has also caused a drop in school enrolment, as children (especially 
girls) are taken out of school to care for sick relatives or assume other responsibilities. In 
Swaziland, school enrolment has fallen by 36 per cent due to AIDS. Child mortality rates 
are also soaring, as the drugs to prevent mother-to-child transmission are not widely 
available in developing countries. There are now 12.1 million AIDS orphans in Africa, a 
number that is expected to more than double over the next decade.
And we might not have seen the worse yet. According to Peter Piot, director- 
general of UNAIDS, “the unprecedented destruction wrought by the HIV/AIDS epidemic 
over the past 20 years will multiply several times in the decades to come, unless the fight 
against this disease is dramatically expanded” (UNAIDS 2002b). Few would dispute the
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fact that “throughout history, few crises have presented such a threat to human health and 
social and economic progress as does the HIV/AIDS epidemic” (Nagarajan 2001). 
However, as Nagarajan points out, “the intensity of this human tragedy has yet to capture 
the undivided attention and wholehearted commitment of the international community.”
The Context o f Liberalization and Globalization 
Neoliberal globalism and globalization
By neoliberal globalism, I refer to the “norms, institutions, and laws that support 
global capital accumulation along neo-liberal principles” (The Globalism Project 2001). 
Neoliberalism entails a set of specific prescriptions, enforced by IFIs through SAPs in the 
South and international trade agreements in the North. These prescriptions include 
opening financial and capital accounts, removing foreign exchange restrictions, cutting 
public expenditures, balancing budgets, lowering corporate taxes, deregulating 
businesses, encouraging foreign investment, selling off public enterprises and securing 
private property monopolies under law (ibid.).
It is important to distinguish between neoliberal globalw/n - an ideology and a 
political project -  and neoliberal global/zar/on, the actual process driven by policy 
choices at the global and national levels, but resulting from the interaction of neoliberal 
policies with a host of other forces. Globalism is both driving globalization, and a 
specific response to the perceived requisites of globalization. In line with Polanyi, 
globalization is conceived here in a dialectical fashion, as being “historically produced 
and politically contestable” (Birchfield 1999: 30).
Like the nineteenth economic liberalism described by Polanyi, neoliberalism 
promotes laissez-faire and free trade as the means to achieve its goal - the establishment
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of a self-regulating market -  and it relies on the support of the global trading classes 
(banks, corporations, investors, etc.). And, like in the nineteenth century, ‘free’ trade in 
fact relies upon the introduction of a complex body of ‘protective’ legislation at the 
regional (e.g. NAFTA) and international (GATS, the TRIPS) levels.
Globalization is of course a complex and multidimensional process. In discussing 
some of its characteristics, I limit myself to those features most relevant to understanding 
the liberalization of health care and the globalization of the pharmaceutical industry.
An outstanding characteristic of the current period of globalization is the 
liberalization of finance, trade and investment. Of the three, the most pronounced is 
financial liberalization,^’ accompanied by increasing instability since most of these 
transactions are speculative in nature. There has also been a moderate increase in trade 
liberalization, but it has been accompanied by the increased use of non-tariff barriers to 
trade. Finally, the liberalization of foreign direct investment (FDI) is also on the rise, but 
this increase is mostly limited to flows among industrialized countries.
This points to an important, and often overlooked, dimension of globalization, the 
fact that it is a very uneven process. Globalization is indeed characterized by 
‘transnationalization,’ i.e. the “growing concentration and monopolization of economic 
resources and power by transnational corporations and by global financial firms and 
funds” (Khor 2000: 10). In this process, vast regions of the world are becoming 
increasingly marginalized in the global economy. Between 1980 and 1995, for example.
The volume traded in the world foreign exchange market grew from a daily average 
of $15 billion in 1973 to over $1,000 billion today (Khor 2000: 8).
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sub-Saharan Africa’s share of world imports and exports decreased, respectively, from 
3.7 to 1.4 per cent, and from 3.1 to 1.5 per cent (Castells 2001c: 83).^*
Another dimension of globalization that has important implications for health is 
the fact that, in both the US and the EU, the service industry has replaced manufacturing 
as the principal source of profits. Expenditures on health in OECD countries is estimated 
at more than US$3 trillion annually (Sexton 2001). Over the last five years, service 
exports have accounted for about a third of economic growth in the US (The Lancet 
2000). In the EU, service industries account for two thirds of the economy, one fourth of 
its total exports and a half of all EU foreign investment (Pollock et al. 2000). The growth 
of the service sector is the main impetus behind the push to expand the role of private 
enterprise in services through agreements such as the General Agreement on Tariffs and 
Services (GATS).
The growth in services has led some to argue that we are moving towards an 
‘intangible economy,’ where the value of goods no longer rests in their physical 
properties, but in their capacity to give access to non-material benefits (Plihon 2001: 13). 
In this new economy, information and knowledge assume new importance.
These changes in economic processes have important implications for society and 
social relations. Building on the ‘time-space compression’ thesis, Castells (2001b:
According to Castells (2001c: 91), rather than outright marginalization, we witness a 
process of ‘selective integration,’ whereby “small segments of African capital, 
affluent markets, and profitable exports” (e.g. oil, gold and diamonds) are integrated 
into global networks of capital, goods and services,” while “most of the economy, and 
the overwhelming majority of the population, are left to their own fate.”
According to the ‘time-space compression’ thesis, the transition from Fordism to a 
regime of flexible accumulation marks a new round of time-space compression 
(Harvey 1990). With the acceleration of economic processes, instantaneity annihilates
42
124) argues that contemporary society is characterized by a fundamental opposition
between two spatial logics, that of the space of flows and that of the space of places:
“What is distinctive of the new social structure, the network society, is that most 
dominant processes, concentrating power, wealth, and information, are organized in 
the space of flows. Most human experience, and meaning, are still locally based. The 
disjunction between the two spatial logics is a fundamental mechanism of domination 
in our societies, because it shifts the core economic, symbolic, and political processes 
away from the realm where social meaning can be constructed and political control 
can be exercised.”
Finally, another important dimension of globalization, and my main focus here, is 
deepening commodification. Global commodification - ‘global’ because it represents a 
new stage in an age-long process, characterized by the extension of the market to new 
areas of social life - has been recognized by many observers as an integral dimension of 
the process of global integration (Appadurai 1986; 1997). It is to this dimension of 
globalization, which has special implications for health - that I will now turn.
Globalization and health: the commodification o f health care
“As its result the drive for a competitive market acquired the irresistible impetus of a 
process of Nature. For the self-regulating market was now believed to follow from the 
inexorable laws of Nature, and the unshackling of the market to be an ineluctable
necessity” 
- Polanyi (1957)
Appadurai’s Social Life o f Things (1986) had an important influence on the way 
in which we think about commodities and the commodification process. Appadurai 
insists that commodities should not be understood as one kind of thing rather than 
another. Indeed, he argues that the “commodity candidacy of things is contingent,” in 
other words that things can move in and out of the commodity realm under different
the barriers of space, with concomitant changes in the meaning and use of space and 
time.
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conditions and over time, and that commodification must thus be understood in context. 
In contrast to the conventional dichotomous view of commodities,'*” Appadurai stresses 
the commodity potential of all things.'** According to this view, commodities are best 
conceived along a continuum, with the vast majority of commodities lying between the 
ideal types of ‘perfect commodity’ and ‘absolute singularity’ (i.e. unavailable for 
exchange) (Helgason and Palsson 1997; Kopytoff 1986). Appadurai sought to break 
away of the view of ‘commoditization’ as a unilineal and irreversible process under 
capitalism,'*^ and emphasized the possibility of shifts and reversals.
While the Marxist view of commodification has been refined, it remains based on 
Marx’s fundamental insight that, through commodification, the exploitative social 
relationships involved in production are hidden and the product made into a neutral 
object with a life and power of its own, a phenomenon referred to as commodity fetishism 
(McMurtry 2001).
More recently, anthropologists have shown how commodification is a complex 
process with historical, political, social and economic dimensions.'*^ While technology, 
by making commodification possible, may act as a trigger, commodification ultimately 
depends on much more complex cultural and political changes.'*'*
'*” Based on the Marxist distinction between exchange value versus use value, objects 
are seen as being either commodities (i.e. inside the economy) or non-commodities 
(i.e. outside the economy).
'** Kopytoff (1986) makes a similar argument in pointing to the fact that the notion of 
‘inalienable goods’ (i.e. goods that are not available for exchange) is not static.
'*^  Hence his use of the term ‘commodification,’ which doesn’t have this connotation.
■*^ See, for example, Appadurai (1986), Hogle (1999) and Kopytoff (1986).
'*'* Hence, for example, in order for body commodification to take place, “human bodies 
must be culturally reclassified as something other than precious human remains, or 
they must be transformed into something that can exist in another category” (Hogle 
1999:42).
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Not surprisingly, commodification is a contested process/^ In the next chapter, I 
will explore in more detail one example of resistance to the commodification of health 
care. For now, let us note that the commodification of previously non-commodified areas 
of social life is one of the core changes that accompanies globalization. One of these 
‘under-commodified’ areas is the sphere of health and the human body.
A ‘market fo r life The commodification o f human life
Alongside older forms of commodification of human life, such as child trade or 
the trafficking of women, we see the development of new forms of commodification 
made possible by the development of biotechnology and medical technologies. In 
Recovering the Nation’s Body, Hogle (1999; 24) challenges the post-modem view that 
the body is becoming fragmented and commodified as never before, and argues that “for 
centuries the body [...] has existed in various property-like states” as revealed, for 
example, by early evidence of the use bodily materials for healing, research and profit. If 
the phenomenon is not new, we may however be witnessing a more complete form of 
commodification, both quantitative and qualitative. Globalization has indeed led to a 
marked increase in the worldwide circulation of human labour, body parts, cadavers, etc. 
Moreover, the traffic in organs and the patenting of life forms are witness to the 
emergence of new forms of commodification of human life.
According to Berthoud (1991: 115), what distinguishes older forms of 
commodification from contemporary ones is “the manner in which human beings may 
now be classified as marketable things: while “in other places and historical periods, the
On resistance to commodification, see Hogle (1999) Kopytoff (1986) and Radin 
(1996).
45
commodification of human beings (slavery is the most obvious example) meant that they 
ceased to be part of the human community, a new extreme is reached, however, when the 
idea of human commodification is seen as legitimate, and justified on grounds of 
individual interest. Berthoud (ibid.: 116) goes on to argue that “the singularity of our 
modernity is obvious when the generalization and extension of the commodity is 
considered.”
Underlying debates over human commodification are two opposing views of the 
body: the body as object/commodity versus the body as inseparable from the person or 
social being. Under the former view, human beings are - to use Polanyi’s expression - 
fictitious commodity par excellence. Indeed, human beings are not produced to be 
bought and sold on the market, and they cannot be detached from the rest of life or 
human activity (Polanyi 1957: 72). With the commodification of an individual’s own 
body, alienation thus reaches new heights (or depths).
While the commodification of human bodies and body parts'*  ^ has recently 
received growing attention,"*  ^ another dimension of the commodification of human life 
whose implications have yet to be fully explored is the commodification of health care.
The commodification o f health care and health services
The commodification of health care -  i.e. the reliance on the market for the 
financing and delivery of health care - is not a new phenomenon. Its roots go back to the 
development, in the seventeenth century, of an engineering approach in thinking about 
the body, which paralleled the increasing mechanization of production. In the course of
i.e. the use of biological materials from the human body (organs, tissues and cells) for 
commercial or experimental purposes (Hogle 1999).
47 See Hogle (1999) and Lock et al. (2000).
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the eighteenth century, health came to be understood as a commodity and the body as 
something that could be improved upon (Chetley 1989; 10). This culminated in the 
nineteenth century doctrine of specific aetiology, which views all diseases as having “a 
specific cause that can be found by examining the body’s biochemical and physiological 
workings” (Lexchin 1984: 209). The increasing commodification of health care that 
occurred throughout this process was crucial to the emergence of the health industry in 
the twentieth century. Health needs gradually came to be seen as “commodities that can 
be profitably supplied by capitalist enterprises like the drug industry” (ibid.: 210).
In the course of the twentieth century, health underwent successive phases of 
commodification and de-commodification. Until the 1930s, health care was treated as a 
full commodity. With the introduction of public health insurance in industrialized 
countries in the second half of the twentieth century, health care was partly de­
commodified, to a greater extent in some countries (for example Canada and France) than 
others (e.g. the US and GB).^ More recently, however, the growth of private insurance 
and the shift to managed care has meant that health care is being re-commodified.
Health care is not a fictitious commodity in the Polanyian sense of the term since 
it is being produced. However, it is not a real commodity either, as it is not produced to 
be bought and sold on the market. Schaniel and Neale (1999) define health care as a 
‘quasi-commodity,’ i.e. as having some, but not all, the characteristics of a commodity. 
Hence, health care is produced, but not for sale on the market; it is demanded by doctors, 
not by patients; and the total cost is unknown until treatment is completed. Health care
See Esping-Andersen, Three Worlds o f Welfare Capitalism (1990) for an attempt to 
measure the extent of de-commodification under the welfare state, and Room (2000) 
for a critique of this analysis.
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can perhaps best be conceived as a form of ‘incomplete commodification.’ Radin (1996) 
developed the notion of incomplete commodification to refer to things that are priced but 
are valued by society independently of their market value because, for example they are 
intrinsically linked to the person or to social relationships.
The liberalization o f health services under the WTO/GATS
The global liberalization of trade represents yet another stage in the process of the 
commodification of health care, whereby not only health goods but health services are 
submitted to the free market, and the role of government in ensuring the provision of 
health care is called into question.
Launched in 1986, the Uruguay Round was perhaps the most ambitious series of 
multilateral trade negotiations aimed at the liberalization of international trade. Whereas 
previous rounds were primarily concerned with the reduction of tariff barriers to trade, 
the Uruguay Round sought to harmonize national policies pertaining to services and to 
IPRs, respectively covered by the GATS and the Trade-Related Aspects of Intellectual 
Property Rights (TRIPS) Agreements (1994). The Uruguay Round culminated in 1995 in 
the creation of the World Trade Organization (WTO), an international organization with 
144 member States'^’ (WHO/EDM 1999).
The General Agreement on Trade in Services (GATS), passed in 1995, aims at, 
on the one hand, expanding the involvement of the private enterprise in the service sector 
and, on the other, forcing governments to open up their public services to foreign 
investors and markets (Sinclair and Grieshaber-Otto 2002). With regard to health care -
As of January 1, 2002
The TRIPS Agreement will be discussed below.
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one of the service sectors covered by the Agreement - GATS threatens to jeopardize tax- 
funded systems based on the principles of shared risk, universal coverage and public 
accountability (Sexton 2001; Shortt 2000). Indeed, it would outlaw the use of non- 
market mechanisms such as cross-subsidization^^ and risk pooling^^ in public services as 
being anti-competitive and restrictive to trade (Pollock et al. 2000). Under the new 
agreement, WTO rules will have precedence over domestic policies and, if the latter are 
found to contravene the WTO rules, countries can be brought before the WTO dispute 
panel and sanctioned (Shortt: 2000).
As we have seen, the push to expand the role of private enterprise in services 
‘coincides’ with the fact that, in both the US and the European Union (EU), the service 
industry^^ is replacing manufacture as the principal source of profits. The push for more 
uniform regulation at the international level is also a response to government health-care 
cost containment measures and to market saturation at home. In this context, US health- 
maintenance organizations (HMOs) '^^ and the pharmaceutical industry seek to restore 
profitability by expanding abroad (Pollock et al. 2000; The Lancet 2000).
Concerns raised by the extension o f the free market to the health-care sector
The GATS was concluded on the understanding that member states could decide 
which services were to be liberalized. Hence, ‘government services’ - services that are
Cross-subsidizing is the use of one service to subsidize another.
Risk pooling is a mechanism for sharing risks and the costs of services across groups 
in society.
The interests of the service industries are represented in the US by the Coalition of 
Service Industries, and in the EU by the European Services Network of Multinational 
industry representatives.
For-profit corporations that contract with medical facilities, physicians and employers 
to provide medical care to groups of individuals (see below).
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not supplied on a commercial or competitive basis - could be excluded from WTO rules. 
The WTO, however, is now challenging this by arguing that in countries where the 
hospital sector is formed of a mix of government and private organizations, foreign 
corporations should be allowed to compete with local ones (The Lancet 2000). WTO is 
also enforcing its regulations more strictly in order to facilitate access to markets and to 
enable states (or the private corporations they represent) to oppose other states’ decisions 
to exclude public services such as health from GATS, thus effectively challenging the 
voluntary nature of the GATS (The Lancet 2000; Price et al. 1999).
Since the GATS conflicts with the principles of universal coverage and health­
care coverage based on shared risk, it leads to the erosion of social welfare provisions and 
the introduction of a system whereby capacity to pay determines access to care.^^ In 
industrialized countries, the effects of the liberalization of health care can already be seen 
with the growing popularity of ‘managed care’ and the proliferation of HMOs. Managed 
care was introduced in an effort to reduce the costs of health care. As one critic observes, 
what is really being managed is not so much health care but its cost (Schaniel and Neale 
1999). Under managed care, health care is no longer provided directly by the public 
sector but by for-profit corporations - known as health maintenance organizations 
(HMOs) - that contract with medical facilities, physicians and employers to provide 
medical care to groups of individuals. The costs are usually paid for by an employer at a 
fixed price per patient. HMOs directly and indirectly control the amount of health care 
that the doctor is allowed to provide to a patient. This represents a significant change
In Canada, these concerns are corroborated by the passing of Alberta’s Health Care 
Protection Bill, which allows private corporations to compete on an equal footing 
with public hospital in the provision of health services. See Shortt (2000).
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since HMOs are for-profit corporations whose responsibilities to stockholders take 
precedence over their responsibilities to patients (HMO 2002)/^
How does managed care reduce the costs of health care? Under managed care, 
HMOs negotiate lower drug prices from manufacturers and manage the drug portion of 
their insurance package: physicians are for example asked to choose from a list of drugs 
selected by HMOs for their efficacy and cost-effectiveness (Landau et al. 1997: 127). 
Ironically in the context of the liberalization of health care, drug prices under this health­
care scheme are not left to the free-market but set through negotiations between drug 
companies and HMOs.
As we will see, developing countries have been subjected to the liberalization of 
health care earlier than industrialized countries and served as ‘testing grounds’ for the 
privatization of health care. Starting in the early 1980s, health reforms implemented in 
the context of SAPs sought to contain costs in the public health sector by allowing the 
private sector to play a greater role in the provision of health services, and made loans 
conditional on the introduction of user fees for health services. In 1987, in a document 
entitled “Financing health services in developing countries: an agenda for reform,” the 
WB recommended the introduction of ‘user fees’ (direct charges for health services), 
decentralization, privatization and the development of health insurance (Save the 
Children 2001: 5).
The GATS represents another stage in the commodification of health services, 
with further liberalization, greater involvement of foreign companies in the health-care
This can, for example, lead HMOs to provide incentive for physicians not to treat 
patients, since the company makes more profits if physicians practice less. See the 
Health maintenance organizations homepage at: www.hmopage.org; Accessed 16 
January 2002.
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sector of developing countries, and the concomitant demise of public health systems. As 
the US Coalition of Service Industries explains, service industries “can make much 
progress in the [GATS] negotiations to allow the opportunity for US businesses to 
expand into foreign health care markets” (Sexton 2001). Developing countries have 
generally made wider commitments to open health-related services to the GATS in the 
hope of attracting foreign direct investment (FDI), and this despite the poor record of 
countries with privatized health care systems/^
Globalization and AIDS
“With free trade the new and tremendous hazards of planetary
interdependence sprang into being” 
- Polanyi (1957; 181)
This section examines the implications of neo-liberal globalization for health by 
examining the impact of neoliberal globalization on the development of the AIDS 
epidemic. Of course, the development of an epidemic such as AIDS is a highly complex 
phenomenon and, in looking at the impact of neoliberal policies on the development of 
the AIDS pandemic, I certainly do not claim that there is a direct causal relationship 
between the two/^
Yet, it has long been recognized that epidemics are as much social and economic 
phenomena as they are biological ones. Throughout history, epidemics have typically
Hence, the US, which has one of the most privatized health care system in the West, 
spends over $1 trillion on health care annually (46 per cent coming from government 
insurance programmes), but 44 million people -  one in six Americans -  do not have 
health insurance.
Nor do I claim to give a comprehensive account of the factors implicated in the size 
and speed of diffusion of the AIDS epidemic. Among the factors that have had an 
impact, but are not discussed here, are gender inequality, social and political violence, 
and the lack of national leadership.
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spread along fault lines of economic structures and hit hardest among socially and 
economically vulnerable populations. The AIDS epidemic is no exception and, as 
Farmer (1992: 9) argues, “a thorough understanding of the AIDS pandemic demands a 
commitment to the concerns of history and political economy.”
My purpose, then, is to trace the complex and multiple ways in which policies and 
processes associated with neoliberal globalization have had an impact on the 
development of the AIDS epidemic. Some processes and policies associated with 
globalization have facilitated the spread of AIDS, either directly -  for example with the 
collapse of public health systems under SAPs - or indirectly (with the increase in 
inequality resulting from neoliberal policies). Other processes associated with 
globalization, for example the declining influence of the WHO and the globalization of 
the pharmaceutical industry, have contributed to the spread of AIDS by hindering an 
effective international response. In still other cases, the impact of neoliberal policies on 
the AIDS pandemic is more direct. Hence, the strengthening of IPRs in international 
agreements poses a direct threat to developing countries’ capacity to produce and procure 
medicines.
Some of the links posited here have been extensively documented. There is 
growing recognition, for example, that neoliberal policies, through their impact on 
poverty and inequality, have played a non-negligible role in fuelling the epidemic 
(Farmer 1999; Garrett; 1994; Kim et al. 2000; Lurie et al. et al. 1995; Sanders and Sambo 
1991). As Butler (2000: 1446) argues: “although poverty is neither necessary nor 
sufficient for an individual to contract HIV infection or AIDS, it may be necessary for an 
epidemic on the scale currently witnessed in parts of sub-Saharan Africa.” Others, such
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as the impact of the shift in global health leadership on the international response to the 
epidemic, need to be explored further. In the following sections, I will take up each of 
these dimensions in turn and attempt to draw an overall picture of the different way in 
which neoliberal globalization has impacted the development of the AIDS pandemic.
New forms o f transnational social inequality
It is increasingly acknowledged, including on the part of the international 
institutions that promote these policies, that market liberalization is often accompanied by 
increasing socio-economic inequality. Hence the IMF (2000: IV/1) estimates that “the 
relative gap between the richest and the poorest countries has continued to widen.” A 
turning point in this debate was the publication of the United Nations Development 
Programme (UNDP) 1999 Report - “Globalization with a Human Face” -  the first time 
that the increasing inequality resulting from globalization was explicitly acknowledged in 
a report of this kind. According to UNDP (1999: 3, 36), the ratio of the income of the 
richest quintile of the world population to the poorest quintile increased from 30:1 in 
1960 to 72:1 in 1997.
The publication, in 2000, of a report on globalization and international inequality 
received a great deal of attention (Melchior et al. 2000). Its authors conclude that 
“international income inequality has decreased continuously from the last part of the 
1960s until 1997” (Melchior et al. 2000: 2).^  ^ The authors do not conclude from this that 
globalization reduces inequality, but they reject “simplified allegations about 
globalization and inequality” (Melchior et al. 2000: 32). While this is not an unheard of
A number of factors (e.g. whether or not China is included, whether income data are 
adjusted for purchasing power difference, etc.) explain that different researchers 
arrive at such contradictory results.
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opinion, it goes against the growing recognition of the increased inequality resulting from 
liberalization. While I agree with Melchior that globalization is a complex phenomena 
with contradictory effects, the evidence shows that the overall effect of liberalization is 
an increase in inter- (as well as intra-) country inequality. Measured by the Gini 
coefficient, world inequality became markedly more unequal between 1988 and 1993, 
rising from 62.5 to 66.0, an increase of just under 6 percent in 5 years (Wade 2001: 11).
Evidence of increasing inequalities at the international level cannot be ignored 
given the growing literature linking higher inequality to poorer health outcomes at the 
population level (Leon 2001; Lynch et al. 2000; Sen 2000; Wilkinson 1996)."^ The 
1990s saw a surge of interest in the relationship between inequality and health, and an 
increasing recognition that inequality (or relative poverty) results in ill-health, 
independently of the contribution of absolute poverty.
I agree with Farmer (1999) and others who argue that social inequality (or relative 
poverty), as distinct from absolute poverty, plays a central role in fuelling emerging 
epidemics. Significantly, the UN AIDS and WHO have recently called the HTV/AIDS 
epidemic “an index of existing social and economic injustices” (UNAIDS/WHO 2001).
^  The relationship between inequality and health remains contentious. Some have 
recently argued that this relationship has been greatly exaggerated (see, for example. 
Judge and Patterson 2001), and there are still people to argue that health and 
inequality are not related in any significant way. See, for example, Deaton (2001). 
There are different explanations as to how unequal income distribution translates into 
poor health. Lynch et al. (2000) distinguish between ‘individual income,’ 
psychosocial, and neo-material interpretations of the association between income 
inequality and health. I personally favour the latter interpretation, whereby the 
association between income inequality and health depends on a community’s 
infrastructure, itself the product of historical, cultural, political and economic factors 
(Judge and Patterson 2001: 17).
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Global shifts in power and influence at the international level are one expression 
of these new forms of transnational social inequality. It is reflected at the health level in 
the shift in global leadership from the WHO to the World Bank (WB) and WTO.
The changing scene o f international health: Shifts in global health leadership
During the first decade of the epidemic, the WHO led international efforts against 
AIDS through its Global Programme on AIDS (GPA). In the mid-1990s, however, the 
WHO, chronically underfunded, rife with rumors of corruption and lacking in leadership, 
lost its status as world leader on global health issues and, in 1996, infighting between the 
WHO and other United Nations (UN) agencies led to the creation of the Joint United 
Nations Programme on AIDS (UNAIDS)^^ (Garrett 2000: 9; Gellman 2000b). In direct 
contradiction to UNAIDS’s stated commitment to “lead, strengthen and support an 
expanded response to the epidemic,” its creation coincided with sharp cutbacks in the 
resources and personnel devoted to AIDS within the various agencies involved (UNAIDS 
2002d).“
Foremost among the international agencies that gradually substituted themselves 
for UN AIDS and the WHO was the WB (Koivusalo and Ollila 1997). By 1996, the WB, 
with a lending portfolio totalling US$13.5 billion of projects, had become the biggest 
public health funder in the world and the single largest funder of AIDS prevention efforts
UN AIDS draws together the UN Children’s Fund (UNICEF), the UN Development 
Programme (UNDP), the UN Population Fund (UNFPA), the UN Educational, 
Scientific and Cultural Organization (UNESCO), the World Health Organization 
(WHO), the World Bank (WB) and the UN International Drug Control Programme 
(UNDCP).
WB loans, for example, dropped from US$50 million dollars to less than US$ 10 
million, WHO spending dropped from US$ 130 million to US$20 million, UNICEF 
from US$45 million to US$10 million (Gellman 2000a).
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in Africa (Garrett 2000: 9; Schaniel et al. 2000: 108). The WHO, in contrast, had a 
budget of US$400 million (Pollock et al. 2002: 1364). The WB has since become 
WHO’s main source of funding.
Given the differences between the two organizations, this shift of influence from 
the WHO to the WB has profound implications. The governing body of the WHO is the 
World Health Assembly (WHA), which meets annually to decide on policy, programme 
and budget. Power at the WHA is based on a “one-state, one-vote” principle. Although 
funding gives industrialized countries greater influence, this voting system ensures that 
developing countries have a voice in decision-making.^'^ Moreover, power at the WHA 
can also be exercised through non-govemmental organizations (NGOs) that have 
consultative status with the WHO. At the WB, in contrast, voting power is determined by 
funding, a system that ensures industrialized countries effective control over decision­
making.^^
Upon starting her mandate as director of the WHO (1998), Gro Brundtland 
stressed the “need to open ourselves to others,” i.e. to the WB, International Monetary 
Fund (IMF) and WTO (quoted in Motchane 2002; my translation). According to her 
cabinet director, the WHO “absolutely needs private financing”: “in the last ten years, 
indeed, [the WHO] has not received much money from governments; money is in the 
private sector and financial markets. And since the American economy is the most 
wealthy on earth, we have to make the WHO attractive to the US and financial markets”
^  This could change, however, as it has been proposed that decision-making power be 
weighted according to the size of a state (measured by its population) and its financial 
contribution (Koivusalo 1997: 8).
The ten richest countries, for example, have over 50 per cent of the voting power 
(Koivusalo 1997: 26).
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(ibid.). Not surprisingly, critics have recently denounced the undue influence exerted by 
private interests on the organization’s orientation and policies (Raghavan 2001b). The 
WHO, they argue, is no longer fulfilling its role as promoter of the interests of 
developing countries at the international level.
A related source of concern is the fact that IFIs are concerned with trade and do 
not have mandates with regards to health. Whereas the WHO’s objective is the 
“attainment by all peoples of the highest possible level of health,” the WTO’s overriding 
objective is “to help trade flow smoothly, freely, fairly and predictably” (Koivusalo and 
Ollila 1997: 6; WTO 2002).
Developing countries and NGOs have sought to counter this shift by giving the 
WHO a role in monitoring the public health implications of international trade 
agreements (Davis 2000; Hayes 2000).^^ The WHO, however, is under pressure from 
pro-trade delegates to endow itself with a mandate to develop trade in health services and 
to promote the benefits of the market for the provision of public services (Aventin 2000; 
Pollock et al. 2002). The outcome of these conflicting pressures remains to be seen.
Health ‘reforms’ and the collapse o f public health systems
The growing influence of the WB and IFIs on global health policy can be seen in 
the implementation of macroeconomic reforms known as structural adjustment programs 
(SAPs). Spearhead of the neoliberal agenda of free-trade and market-oriented 
economies, SAPs introduced policy-based lending in the form of loans conditional on the 
adoption of a series of measures promoting privatization, liberalization and economic
^  See Nader (2(X)1) and Zeltner (2(XX)).
See Resolution 52.19 (1999) and 53.14 (2000) of the World Health Assembly, 
available at www.who.int.
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deregulation. In line with these objectives, health reforms implemented in the context of 
SAPs sought to contain costs in the public health sector by allowing the private sector to 
play a greater role in the provision of health services. These reforms resulted in declining 
infrastructural investments and the implementation of cost-recovery in the forms of user 
fees.
These policies were further developed in the 1993 World Development Report 
entitled “Investing in Health.” In this document, the WB recognizes that governments 
have a regulatory role to play, but limits their role to public health measures and to 
ensuring access to essential services for the poor (Koivusalo and Ollila 1997:142). This 
report is witness to the emergence of a model of health care in which governments are 
responsible for policy-making and regulation, while the private sector provides health 
services on a competitive basis (ibid.: 141).
The reforms demanded by the WB have been described as “badly conceived and 
poorly implemented” but, more importantly, have been seen as a major threat to equity 
(Save the Children 2001: 5). Critics are concerned that these reforms undermine both 
access to health care (through the imposition of user fees for example), and the provision 
of health care (through cuts in government expenditure), thereby directly contributing to 
increases in mortality in the 1990s (Save the Children 2001; Schoepf et al. 2000; Stott 
1999). Of course, SAPs are not the only factor behind the severe decline in the provision 
of health services in the 1980s and 1990s, and it can be argued that other factors, such as 
the economic crisis and mismanagement, also played a role. The role of health reforms, 
however, was important enough to lead some to argue that the mortality crisis of the 
1990s in Africa was “policy-induced” (Save the Children 2001).
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As their human cost became apparent, health reforms came under increasing 
criticism. The WB responded by including in its analysis the social dimensions of 
structural adjustment. As Koivusalo and Ollila (1997:40) argue, however, the rhetoric 
about poverty alleviation and more equitable health care has not altered the underlying 
market-oriented logic of the WB health policies.
A striking example of the impact of health reform on inequality and health is the 
introduction of direct charges for health services. Perhaps the most controversial aspect 
of the health reforms promoted by the WB, user fees were based on the view that 
utilization of services was largely unresponsive to prices, a view that has subsequently 
been refuted (Save the Children 2001: 6). Indeed, studies have shown that user fees have 
led to a decline in the use of health services among low-income segments of the 
population, thereby increasing inequalities in access to health care.^
In the longer term, health reforms create a two-tier health system. In its 1987 
“Agenda for Reform,” the WB explicitly promotes a health system made up of “a 
combination of privately run and financed curative services complemented by public 
health programmes targeted at certain classes of patients” (Koivusalo and Ollila 1997: 
33). This system, it is said, will enhance equity as public resources are targeted at the 
poor. In reality, however, such a system has the opposite effect: in the face of the 
deteriorating quality of public health, those who can afford it seek private care, and the 
quality of public services deteriorates as they are chronically underfunded and serve a
Ironically, the ‘rationale’ behind the introduction of user fees was that it would 
promote access to health care for the poor. Indeed, it was claimed that user fees 
would discourage the urban non-poor from making excessive use of government 
public health services, thus making them available for the poor (Save the Children 
2001).
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constituency with little political power. In other words, the greater the inequality, the less 
political will there is to invest in public health.
In sum, while much of the more recent rhetoric around health reforms has 
emphasized equity in access to health care, these reforms are first and foremost about 
diminishing the cost of public financing of health-care services. Given the WB’s 
emphasis on liberalization, competition and private financing, these reforms in fact 
compromise equity in access to health services. The next section moves beyond this 
general discussion of the health impact of SAPs to illustrate the specific mechanisms 
through which health reforms have contributed to the development of the AIDS 
epidemic.
Mechanisms by which health reform fuelled the AIDS epidemic
Structural adjustment policies have worked at multiple levels to increase 
vulnerability to AIDS, especially among the poor. At the most obvious level, cuts in 
social spending required under SAPs have reduced the resources available for AIDS 
prevention, treatment and care. Health spending for all developing countries (excluding 
China and India) declined from 5.5 to 2.8 per cent of national budgets between 1972 and 
1988 (Lurie 1995: 543). Some countries experienced rapid and substantial drops in 
health spending, ranging from 20 per cent to 30 per cent (Ashtana 1994: 59).
Structural adjustment policies have thus facilitated the spread of AIDS by cutting 
back on the quality of health care while at the same time limiting access to health 
services. As noted earlier, measures such as the introduction of user fees and cuts in
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health services have further reduced (already severely limited) access to health care.^ 
This has led, for example, to a recrudescence of untreated sexually-transmitted diseases 
(STDs), an important co-factor in the transmission of HIV. Severe budget cuts under 
structural adjustment policies have also meant a reduction in the quality of health care, as 
overworked staff are forced to work with inadequate supplies of drugs and lack basic 
medical supplies (Schoepf et al. 2000:112).
More insidiously, SAPs have increased vulnerability to AIDS through their 
impact on poverty and inequality. At the same time as the cost of health care increases, 
decreased income as a result of devaluation and cuts in the public sector limits people’s 
ability to afford health care. Moreover, cuts in subsidies and the removal of price 
controls on basic commodities have increased the incidence of malnutrition. This is 
significant because malnutrition and infection are synergetic: a low nutritional status 
predisposes an individual to infection and increases the severity of the infection, while 
infection in turn causes further malnutrition (Asthana 1994). Cuts in government 
expenditure have also meant a further deterioration in the provision and maintenance of 
basic infrastructure, which increases exposure to infectious diseases. Finally, the 
contraction of the urban informal sector and rural-urban migration resulting from the 
promotion of cash crops increase women’s economic vulnerability and can push them 
into economic prostitution, thus putting them at risk of contracting AIDS (ibid.).
In Burkina Faso, for example, it is estimated that only 14 per cent of patients with 
severe diseases make use of health services (WHO/WB 1994, quoted in Save the 
Children 2001: 4).
62
The transnational concentration o f capital and the globalization o f the pharmaceutical 
industry
Turning from public health policy to corporate policy, the generalized slowdown 
in economic growth in the industrialized world that began in the 1970s had two 
consecutive and opposite effects on the pharmaceutical industry. At first, the industry 
benefited from the redirection of flows of capital away from the traditional manufacturing 
sector towards more technology-intensive research-based industries with higher rates of 
return on capital (Landau et al. 1997: 114). This reflects the fact that pharmaceutical 
markets are not cyclical and are partially protected from economic downturn by private 
and public health insurance. The 1980s were thus an outstanding period for the 
pharmaceutical industry, both commercially and technologically. It is during this period 
that the industry completed the shift from organic chemistry to biotechnology. The 1980s 
also saw the discovery of ‘blockbuster drugs,’ i.e. breakthrough drugs (for example 
antibacterial, cardiovascular and analgesic drugs) that reach annual sales of $1 billion and 
more. While the industry only saw a moderate increase in sales during this period, its 
profits increased substantially (ibid.).
By the 1990s, however, weak economic growth had eroded the financial basis for 
both private and public health insurance systems and health-care costs were rising due to 
the aging of the population. Industrialized countries introduced cost-containment 
measures, such as stricter controls on the price of medications, the withdrawal of 
reimbursements from selected products and increases in the contribution of the insured. 
Drug companies saw their profitability decrease as governments sought to contain 
spiraling health-care costs by introducing price controls and promoting the use of generic 
drugs. The problem, however, was not the erosion of profitability but the deceleration of
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growth: profitability in the early 1990s was higher than ever before (partly because of the 
divestitures of non-health-related businesses), but rates of increase in annual sales were 
lower than in the 1980s (ibid.: 122).
The 1990s also saw the gradual erosion of multinationals’ supremacy as some 
developing countries, especially in Asia, acquired the technological knowledge and 
capacity to produce pharmaceuticals. At the same time, globalization and trade 
liberalization were facilitating the imitation of branded products, resulting in financial 
losses for multinational companies (WHO/EDM 1999: 38). Finally, tighter government 
regulations and a longer approval process increased R&D costs and reduced the period of 
effective patent protection. Shrinking traditional markets and pricing pressure, combined 
with a slowdown in innovation and patent expirations, led to a wave of restructuring and 
consolidation of the industry.
These changes did not erode the industry’s profitability (which has been 
consistently high), but they slowed its growth. To widen its markets and ensure sustained 
growth, the industry adopted a number of strategies. The industry’s short-term strategy 
was to ‘rationalize and restructure’ its operations: it consolidated and restructured its 
manufacturing and distribution networks, reorganized its operations to reduce its work­
force and in some cases closed down manufacturing plants (Landau et al. 1997: 125). It 
also divested many of the non-health-related businesses to concentrate on the more 
profitable pharmaceuticals.
In the longer term, the industry’s response was to consolidate itself. In the early 
1990s, it entered a frantic round of mergers, acquisitions and joint ventures. According 
to industry analysts, the recent acquisition by Pfizer of Phamarcia (July 2002)
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foreshadows a new round of consolidation in the industry (AFP 2002). Consolidation is 
aimed, first of all, at strengthening a drug company’s position in existing markets 
(horizontal diversification) by expanding its product lines and entering into joint ventures 
with biotechnology companies whereby expertise is exchanged for funding of R&D and 
marketing. Consolidation also aims at entering the growing generic and over-the-counter 
(OTC) markets (vertical diversification). This was prompted by the expiration of patents 
on several drugs with large markets and the fact that public and private health insurers 
advocated the use of (cheaper) generics.’® Dmg companies responded by taking over and 
forging alliances with producers of generics and OTCs and with mass distributors in 
order to market drugs more effectively at lower cost in the countries with the highest 
consumption. Finally, consolidation aims at expanding into the underserved areas of the 
world. Since the traditional US, European and Japanese markets had reached maturity, 
the industry expanded in the less profitable but potentially large markets of the 
developing world, e.g. China, the countries of the Pacific Rim, some Latin American 
countries (like Mexico and Brazil), Russia and Eastern Europe. According to Tarabusi 
and Vickery, a central part of the explanation for the ‘success’ of the drug industry lies in 
this pattern of globalization developed by the industry (Landau et al. 1997; Tarabusi and 
Vickery 1993).
The strengthening o f intellectual property rights in international agreements
The drug industry also responded by pressuring governments into pushing for 
more stringent and uniform patent protection at the international level. Its role in
A generic drug contains the same active ingredients as the original brand drug and is 
usually marketed after the expiry of patent rights.
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formulating the TRIPS Agreement is revealed by the following comment made by an 
industry representative: “industry [...] crafted a solution, reduced it to a concrete 
proposal and sold it to our own and other governments” (Oh 2000).
Trade-Related Aspects o f Intellectual Property Rights (TRIPS)
With regards to pharmaceuticals, the TRIPS Agreement introduces ‘universal’ 
minimum standards of IPR protection which, in practice, means extending industrialized 
countries’ standards to the developing world. The irony, of course, is that through these 
agreements, industrialized countries prohibit the very practices they themselves used in 
the past (and in some cases are still using) to develop their drug industry by imitating and 
copying existing technologies. Because of this, IPR protection can be seen as “a tool to 
guarantee the comparative advantage that had so far ensured the developed countries’ 
technological supremacy” (ibid.).
The TRIPS Agreement both extends and strengthens the monopoly protection of 
pharmaceuticals: it introduces a minimum term of patent protection of twenty years, and 
extends the scope of patent protection to both products and processes. This represents a 
major change since, prior to TRIPS, many developing countries, in order to promote 
access to drugs at competitive prices, did not confer patent protection on pharmaceuticals 
(ibid.). Moreover, the Agreement introduces a legal mechanism to enforce compliance 
with TRIPS provisions, which means that countries whose national patent laws do not 
conform to patent protection under TRIPS can be the subject of a complaint before the 
WTO Dispute Settlement Body, as has already been the case (WHO/EDM 1999: 21). For 
the first time, the same standards are applied to all countries irrespective of their level of
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development. The only concession made to developing countries is that they benefit 
from a longer period of transition.
Implications o f TRIPS for access to drugs in the developing world
It is generally accepted that the TRIPS Agreement will have a negative impact on 
access to medicines in the developing world. The authors of a WHO report on its 
implications for access to drugs conclude that it will have an adverse effect on prices and 
access to technology (WHO/EDM 1999: 39). According to some, the Agreement 
amounts to the “sanctioning of monopoly pricing of new drugs” (Baris and McLeod 
2000: 193). The extension and strengthening of patent protection is likely to result in 
higher prices for patented drugs, while at the same time restricting the scope for generic 
alternatives.
In the longer term, the fact that, for the first time, the same standards are applied 
to all countries irrespective of their level of development is a threat to the development of 
indigenous pharmaceutical industries (Oh 2000; WHO/EDM 1999: 38). Indeed, TRIPS 
makes it extremely difficult for developing countries to develop their own technology by 
copying products through reverse engineering.^^ A WHO study (1999) on the 
implications of the WTO/TRIPS Agreement for the Thai pharmaceutical industry 
concludes that there has been no significant increase in transfer of technology or foreign 
direct investment following Thailand’s 1992 patent law revision (which essentially 
follows TRIPS standards), and that originator firms have done better than domestic 
generic firms (Scholtz 1999).
Reverse engineering refers to the manufacturing of a product starting from the 
finished product. This practice has often been used to copy original drugs in countries 
that did not allow patenting of pharmaceuticals.
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Nevertheless, a number of provisions allow for “exceptions to the exclusive 
rights” of the patent holder, provided they are limited, duly justified, and do not 
“unreasonably prejudice the legitimate interests of the patent owner” (Article 30). Hence, 
the TRIPS Agreement “does not prohibit Members from applying the principle of 
international exhaustion -  that is, allowing parallel importation of patented 
pharmaceuticals once they have been placed on the market in any country” (Article 6 )P  
Moreover, Article 31 permits the use of compulsory licensing, for public non-commercial 
use or in conditions of emergency for example.^^ Finally, Article 27 allows for the 
exclusion from patentability of certain “subject matters,” including “therapeutic methods 
for the treatment of humans” (WHO 2001).
For the potential of these provisions to be realized, however, they must be 
incorporated into national legislation during the transition period. The length of the 
transitional period varies according to the level of economic development: industrialized 
countries have one year to conform to WTO rules, developing countries five to ten years 
(depending on whether they already conferred patents on pharmaceuticals), and the least 
developed countries twenty years. But in practice, those countries who have attempted to 
avail themselves of these options have come under intense pressure from industrialized 
countries not to do so.^^
Parallel importation refers to the importation (without the agreement of the patent 
holder) of a drug sold at a cheaper price by the same company or its licensee in 
another country.
Compulsory licensing refers to the granting by national public authorities of a license 
to exploit a patent without the owner’s consent, when justified by the general interest, 
and provided compensation is given to the patent holder.
Ironically, the US, the most ardent proponent of the strengthening of patent rights in 
international agreements, is now considering limiting monopoly protection of 
pharmaceuticals at home. Indeed, faced last year with a 17 per cent increase in the
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A Giant Case o f Market Failure: Globalization and Access to AIDS Treatment in the 
South
“There is no marketplace to speak of in the poor world”
- Dr. Harvey Bale Jr.^^
International Federation o f Pharmaceutical Manufacturers Associations (IFPMAf^
With the settling in of neo-liberal, market-driven forces, the concomitant 
expansion of multinational enterprises and the consolidation of patent rights in 
international agreements, the commodification of health care entered a new stage in the 
early 1990s, whereby drugs become fully tradable goods, without regard to their nature or 
effects. While the process is no different in essence - in Berthoud’s (1991: 118) words, 
“market forces continue to annex new spaces” - with the commodification of health, the 
market logic is reaching deeper into society. What is at stake now is no longer ‘man as 
labour,’ but human beings themselves in their capacity to live long and healthy lives. 
The political, social and economic impact of economic liberalism is, if anything, 
comparable to the impact of the industrial revolution in the extent of suffering and social 
dislocation it engenders.
As I have argued in this chapter, all the changes discussed above are implicated in 
the development of AIDS and help explain the striking international pattern of the 
pandemic. Heightened forms of inequality at the global level - the most striking being
costs of prescription medicines, thirty seven states are considering laws to limit 
pharmaceutical costs and there is also talk of a Congressional bill limiting drug 
companies’ monopoly on new drugs (Brown 2002).
Quoted in Garrett (2000)
Created in 1968, the International Federation o f Pharmaceutical Manufacturers 
Associations (IFPMA) represents the industry’s interests at the international level. It 
has consultative status with many United Nations agencies and other international 
organizations, and is a powerful lobby group with the capacity to shape national and 
international policy.
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lack of access to drugs in the South - fuelled the epidemic precisely at a time when public 
health systems were under attack by SAPs and when the international organizations best 
positioned to respond to the challenge were being weakened. Ironically, the 
strengthening of IPRs is taking place at the same time as the deregulation of the health­
care sector, revealing the contradictions inherent to neo-liberalism’s emphasis on ‘free’ 
trade and the free-market. The coming together of these interrelated trends goes a long 
way in explaining the development of a two-speed epidemic.
Significantly, the development of the AIDS pandemic along the fault lines of 
poverty and deprivation has promoted growing awareness of the harmful effects of the 
global economic system for the health of large segments of the population. With 40 
million people infected with HIV/AIDS worldwide - 95 per cent of whom live in the 
developing world - the Director-General of the IFPMA’s assertion that “there is no 
marketplace to speak of in the poor world” is shocking.
The significance of the AIDS pandemic is precisely that it has revealed the failure 
of the free market to meet the health needs of the population worldwide. As a 
spokesperson for South African’s Ministry of Health recognized, “the problems in getting 
universal access are so deep [that] we need major structural intervention” (Cooper et al. 
2001). Heightened political consciousness is revealed in the growing international 
mobilization around health issues, the most striking example of which is the growth of a 
TAN around the issue of access to AIDS treatment in the South.
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CHAPTER THREE
Society’s Response: The Development of an AIDS TAN
“For a century the dynamics of modem society was governed by a double movement: the 
market expanded continuously but this movement was met by a countermovement
checking the expansion in definite directions.”
- Polanyi (1957: 130)
“Can it be expected that the extraordinary mass of suffering produced by this sort of 
political-economic regime will one day serve as the starting-point of a movement capable
of stopping the race to the abyss?” 
- Bourdieu (1998)
This chapter examines the development of a TAN around the issue of access to 
AIDS treatment in the South. The objective of this chapter is not to write a 
comprehensive history of the AIDS TAN, nor is it to write an in-depth analysis of the 
movement. Rather, 1 will attempt, building on the argument made in preceding chapters, 
to determine whether the development of a transnational AIDS advocacy network can be 
said to reflect the idea of a movement of social protection against the expansion of 
economic liberalism.
This requires some background into the history and nature of the network. 
Firstly, 1 will present a brief historical overview of the development of this network, 
tracing its roots to the gay liberation movement of the 1960s and to early treatment 
activism in the US and Europe.^ While treatment advocacy is not new, it was only 
following the advent of Highly Active Anti-Retroviral Therapy (HAART) that we saw 
the formation of a TAN around the issue of access to treatment in the South. Here, 1 
follow Keck and Sikkink (1998) in distinguishing transnational advocacy networks 
(TANs) from the more loosely defined ‘transnational social movements’ (TSMs).
Transnational AIDS advocacy is also indebted to older examples of transnational 
advocacy, such as the network formed around human rights.
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In the second section, I will analyze the AIDS TAN by mapping the network, i.e. 
what kind of organizations participate in the network, and explain its objectives and the 
strategies put forward to meet them. This will be illustrated by a concrete example of a 
campaign undertaken by the network. Finally, I will attempt to take stock of the 
network’s successes and failures to this date.
I will then turn to a discussion of the central issue of this thesis, and examine the 
extent to which the AIDS TAN constitutes an example of the double movement, as well 
as the extent to which Polanyi's theories are useful in interpreting the global era. The 
discussion is organized around Polanyi’s three criteria of what defines the principle of 
social protection, namely a movement’s aim, membership (or participation)^* and 
methods. While the principle of economic liberalism has remained essentially the same 
(see chapter two), the principle of social protection has undergone significant 
transformation. This is mostly because it operates in a fundamentally different context. 
Some of these changes, and how social movements have responded to them, will also be 
discussed. Finally, the last section addresses some important questions as to the 
implications of this new form of advocacy, for example the implications of ideas of 
‘global health rights’ and ‘therapeutic citizenship’ for the way in which we conceive of 
citizenship.
Origins: the AIDS Movement
AIDS activism dates back to the early years of the epidemic (i.e. the early/mid 
1980s). What came to be known as “the AIDS movement” arose, in part, out of the
78 Given the very flexible nature of participation in the AIDS TAN, I prefer the term 
‘participation’ to the more formal ‘membership’ category used by Polanyi.
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lesbian and gay liberation movement of the 1970s and early 1980s. Activists who joined 
the AIDS movement, however, also came from the ranks of other social movements of 
the 1970s, such as the feminist health movement and the peace movement.
The AIDS movement is broad-based and diverse: not only does it encompass a 
wide range of grassroots activists, service providers, and community-based organizations, 
but it includes members from the various communities and constituencies affected by the 
AIDS epidemic (i.e. gays and lesbians, people with haemophilia, injection drug users, 
etc.) (Epstein 1996: 8).
In the late 1980s, stigmatization, the slowness of the US government to respond to 
the epidemic and the lack of availability of effective therapies spurred a new and more 
radical phase of AIDS activism, epitomized in the creation (1987) of the AIDS Coalition 
To Unleash Power (ACT UP) (Epstein 1997: 420; Wachter 1992: 128).
The late 1980s also saw the formation in the US of the AIDS Treatment Activist 
Movement, as some groups within the AIDS movement gradually became interested in 
issues of medical treatment and research for AIDS. Epstein (1996) highlights the 
distinctive character of the ADDS movement, especially in its active engagement with 
biomedical research and practice. In becoming ‘credible interlocutors’ of the medical 
and research establishment, treatment activists succeeded in questioning and influencing 
issues as diverse as research and funding priorities, the conduct of trials, and drug 
regulations (Adam 1997: 31; Epstein 1996).
At first, ADDS activists focused their attention on access to experimental 
medication and the high price of AZT, and their target was the pharmaceutical industry 
(Stolberg 2001). The immediate effect of the discovery of triple therapy in 1996, which
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turned the killer disease into a chronic illness, was to quieten AIDS activism against drug 
companies in the West. However, lack of access in the US because of high prices soon 
revived the issue of the affordability of treatment. At the same time, the drug industry’s 
lobbying offensive, in a context of growing concern with the effects of globalization, 
contributed to put the issue of access to AIDS therapy in the limelight.
Early AIDS activism was of course an important formative influence on 
international AIDS advocacy. In many ways, the AIDS movement that developed in the 
US constituted the basis for the subsequent formation of a transnational AIDS advocacy 
network.
As Bastos (1999: 33) documents in her study of global responses to AIDS, the 
fight against AIDS, however, took a very different form in developing countries, where 
AIDS efforts hardly had any connection to local gay activism and grew “in strict 
cooperation with development agencies.” This is not surprising given that gay activism 
in most developing countries was not as prominent (or virtually non-existent), that the 
AIDS epidemic was primarily a heterosexual one, and that local efforts were largely 
dependent on foreign money and technical know-how. In these countries, the NGO 
response to AIDS has most often been built on women’s groups (O’Malley et al. 1996: 
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It is in the latter part of the 1980s that NGOs, governmental agencies and 
intergovernmental organizations, who had until then worked in isolation, began to 
develop ties (O’Malley et al. 1996: 356). International conferences facilitated the 
formation of networks and federations of NGOs and, in 1988, WHO organized the first 
meeting of AIDS NGOs, which resulted in the creation of the International Council of
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AIDS service organizations (ICASO). At the same time, governmental and 
intergovernmental organizations increased cooperation with NGOs, a policy that 
recognized NGOs’ strengths and success while conveniently serving the objective of the 
privatization of state functions (ibid.: 357).
“A lightning rod fo r  protest The advent o f HAART and mobilization fo r  access to
AIDS treatment in the South
The discovery, in the mid-90s, of Highly Active Antiretroviral Therapy (HAART) 
marked a turning point in AIDS advocacy. The announcement of encouraging results at 
the 1996 International Conference on AIDS (Vancouver) indeed put an end to over a 
decade of dire predictions and fmstrated hopes.
The discovery of HAART also changed the scene for AIDS activism. Indeed, as 
the initial enthusiasm receded, it rapidly became clear that the theme of the Conference -  
“One World, One Hope” -  was over-optimistic, and that the exorbitant price of tri- 
therapy®° in fact kept it out of reach of the vast majority of the world’s population. A 
perverse effect of this discovery was that, once it became clear, thanks to combination 
antiretrovirals, that the AIDS epidemic could be contained in the industrialized world, the 
third world pandemic lost its urgency in the eyes of the international community 
(Gellman 2000a).
But the discovery of HAART had other unforeseen consequences, as it “escalated 
the level of socially acceptable public health disparity in the world” (Garrett 2000: 575). 
As already mentioned, the exorbitant price of tri-therapy kept it out of reach for the 95
The expression is from Garrett (2000).
When it was first put on the market, the cost of tri-therapy was over $10,000 per 
year/per patient.
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per cent of people with HIV/AIDS living in the developing world. As Farmer (1999:
267) points out, the irony of medical advances in a context of deepening inequality is that 
“the better the therapy, the more injustice meted out to those not treated.”
The discovery of HAART eventually prompted the formation of a transnational 
AIDS advocacy network. As we have seen, there was a dynamic US-based AIDS 
advocacy movement prior to the advent of HAART. The various components of the 
movement had developed international links (through, for example, their participation in 
international conferences), but remained only loosely connected. The issue of access to 
treatment in the South, however, provided the conditions for the formation of a TAN. 
Indeed, it offered a specific issue around which to focus advocacy efforts, one, moreover, 
that required action at multiple levels: national (national AIDS programmes and policies), 
intergovernmental (bilateral aid) and international (international funding schemes, 
WHO/UN ADDS policies and international IPRs agreement). It is thus only with the 
discovery of HAART that we see the formation of a TAN around the issue of access to 
treatment.
My discussion of AIDS advocacy as a network of advocates working 
internationally draws on the work of Keck and Sikkink, who first introduced the concept 
of transnational advocacy network in their breakthrough study of contemporary social 
movements - Activists Beyond Borders: Activists Networks in International Politics 
(1998). While Keck and Sikkink discuss the human rights network, the environmental 
network and the network on violence against women, many of their insights apply 
equally to the network of activists working on access to treatment for people living with 
mV/AIDS.
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International advocacy around access to AIDS treatment meets Keck and 
Sikkink’s definition of transnational AIDS advocacy. This will be discussed in more 
detail in the next section. For now, let us simply note that it consists of actors that work 
internationally on an issue - access to AIDS treatment in developing countries - to 
promote social change, for example in national policies or in international trade 
agreements. Keck and Sikkink (1998: 2) define TANs as including “those actors working 
internationally on an issue, who are bound together by shared values, a common 
discourse, and dense exchanges of information and services. TANs are seen as 
communicative structures as much as political ones. While the network retains a flexible 
organizational structure, campaigns and actions are sufficiently structured to talk of a 
‘network’ (as opposed to the more loosely defined ‘movement’). The term ‘advocacy’ 
indicates what is central about these networks: the fact that they are organized “to 
promote causes, principled ideas and norms, and often involve individuals advocating 
policy changes that cannot be easily linked to their interests” (ibid.: 8). Activist networks 
are distinguished from other types of transnational networks (such as economic actors 
and networks of scientists and experts) by “the centrality of principled ideas in 
motivating their formation” (ibid.: 1). Finally; the network’s professionalism, and the 
density and complexity of its international linkages warrants the term ‘transnational’.
Some have questioned the newness of the concept of TAN. How does this
concept differ, for example, from that of ‘transnational social movement’ (TSMs)? As
Tarrow (1998: 192) puts it:
“What seems to be qualitatively new is that, unlike the international working-class 
movement of the past, TANs are not locked teleologically into a fixed social 
movement; their geographical mobility, loose organizational models, and access to 
communications provide the capacity to shift their campaigns and resources to venues
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in which they have the strongest chance to succeed; and they can draw upon the 
elements of common cultural framing that economic globalization and the 
communication revolution have brought to many comers of the world.”
According to Tarrow, TANs are thus analytically distinct from TSMs, more 
loosely defined as “ongoing collective efforts to bring about consequential social change” 
at the international level (McCarthy 1997: 244). Another difference lies in their 
respective composition. TANs bring together nongovernmental, governmental and 
intergovernmental organizations; the AIDS TAN, for example, includes national and 
international NGOs (e.g. the Consumer Project on Technology (CPT/US), but also 
intergovernmental organizations such as the WHO. TSMs, in contrast, are formed of 
social movement organizations who may, or may not, form alliances with NGOs or 
intergovernmental organizations (ibid.: 150).
Now that we have seen how the issue of access to treatment emerged on the 
international scene, let us look at the nature of this debate and the arguments put forward 
by proponents and opponents of universal access to ARVs.
The debate over access to AIDS drugs
A  widespread argument for limiting access to tri-therapy is that it is not ‘cost- 
effective’ in third world settings; in other words, that limited health resources could be 
spent more advantageously on prevention or treatment of opportunistic infections than on 
expensive ARVs. Ainsworth and Beokul (2000: 58) go further and argue that “even if 
the drugs were cheap, this type of therapy would probably not be cost-effective [...] 
compared with treatment of opportunistic infections because of problems with non- 
compliance and erratic supplies of drugs.” In the face of poor infrastructure and low
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level of health expenditure, universal access to care and treatment for HTV/AIDS is said 
to represent “ill-advised and injudicious public-health practice” (Adler 1998: 232).
Advocates of universal access to ARVs denounce such arguments as reflecting a 
“differential valuation of human life” (Farmer 1999: 278). Issues of cost-effectiveness, 
they argue, ignore the underlying cause of lack of access, namely the “fundamental 
nature of the pharmaceutical market and the way in which it is regulated” (Pécoul et al. 
1999). Since health is a fundamental human right, being denied access to health care for 
economic reasons is a human rights issue.
The pharmaceutical industry insists that its “primary role in combating HIV/AIDS 
worldwide is through its unique role in the discovery and development of new vaccines, 
medicines and treatments,” and that the protection of IPRs is essential in order to promote 
such research (IFPMA 2000). According to the industry, measures such as parallel 
importation or import substitution, while they can appear attractive in the short term, will 
undermine research and thus work against developing countries’ interest in the longer 
term. It is an interesting paradox that the industry, while justifying patents and the use of 
brand names on the grounds that “any industry which is based on innovation must be 
protected from the unfettered forces of pure price competition” (Walton et al. 1986: 
1039), opposes attempts to improve access to drugs through mechanisms such as parallel 
importation or generic substitution on the grounds that it interferes with the free market.
Proponents of stronger patent protection also argue that it is needed to overcome 
the “significant political and regulatory constraints” that are deterring pharmaceutical 
companies from developing products that could benefit the health of people in the 
developing world. These constraints include “failure to respect and enforce intellectual
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property rights, drug piracy, pricing restrictions, and lack of consistency in standards of 
regulation and enforcement” (Howson et ai. 1998: 588). Stronger patent protection, it is 
argued, means more incentive to invest in R&D, and hence more new products that could 
profit developing countries.
This optimistic assessment of the impact of patent protection for developing 
countries, however, is not shared by everyone. Scherer (2000) estimates that “to 
compensate for the loss of domestic surplus as a result of high drug prices for existing 
patented products, a threefold increase in the number of equivalent new products 
reaching the [less developed countries] would be required.” It is “highly improbable,” he 
concludes, “that such a large increase in new products could be driven solely by the 
modest sales increase attributable to newly-authorized patenting in low-income nations” 
(ibid.). Moreover, since research is driven by market demand in industrialized countries, 
it is doubtful that, in the absence of incentives, research will be targeted towards diseases 
prevalent in the developing world.
Activists, in contrast, stress the need for a balance between IPRs and public 
health, provided the former does not take precedence over the latter. While they 
recognize that protection of patent rights is necessary to stimulate R&D, advocates argue 
that these claims are extremely weak in the case of ARVs, since most were developed in 
public research institutes and adopted in relatively short time-frames (Chirac et al. 2000). 
Hence, the Pharmaceutical Research and Manufacturers of America (PhRMA) estimates 
that private industry finances 43 per cent of drug development (PhRMA 2000: 23). 
Antiretrovirals were approved in an average of 44.6 months, close to half the industry­
wide average of 87.4 months for the approval of drugs (Chirac et al. 2000).
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A central tenet of the industry’s position is that high prices are only one among a 
variety of obstacles to access to drugs in the developing world. Hence, the 
Pharmaceutical Research Manufacturers o f America argues that “in the developing 
world, endemic problems o f poverty, ignorance, neglect and corruption undercut meager 
health services, keep populations isolated, perpetuate risky behavior and render drugs 
alone ineffective” (PhRMA 2001; my emphasis).
AIDS activists do not deny that infrastructural problems have to be tackled in 
order for AIDS therapy to be made widely available. However, they object to this being 
used to avoid discussion of the drugs’ high prices. Efforts focusing on prevention, they 
argue, are to no avail in the absence of treatment. Since treatment provides an incentive 
for people to get tested, it is an essential component of effective prevention.
The risk of development of multidrug-resistant strains is also widely cited as one 
reason to limit the use of ARVs. Because of patients’ non-compliance, the argument 
goes, increasing access to AIDS drugs in the developing world is tantamount to a public 
health risk. The compliance argument is a classic example of the “blaming-the-victim” 
ideology. The focus is on whether patients comply with the prescribed treatment, their 
failure to do so being interpreted as a mark of irresponsibility or irrationality.** 
Arguments about compliance exaggerate people’s agency, as no attention is paid to 
external factors that may prevent a patient from pursuing the treatment (Farmer 1999:
268). The irony of using compliance to justify limiting access to therapy is, of course.
** Similar arguments have been made in the US, where “noncompliance” has been used 
as one reason for limiting access to antiretrovirals for the poor (Farmer 1999: 267- 
7oy
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that economic barriers are a major reason why people cannot afford to follow the 
treatment in the first place.
The next section discusses in more detail the nature of the AIDS TAN, its 
objectives, composition and strategies. This will be illustrated by a concrete example of a 
campaign undertaken by the AIDS TAN -  the South African campaign (April 2001) -  
and followed by a discussion of the network’s successes and failures to date.
Analyzing the AIDS TAN
We have seen how the discovery of HAART raised the stakes of access to HTV- 
AIDS medicines in developing countries. In the course of the following years, as more 
and more organizations became involved in the issue, they gradually developed ties 
among themselves. Given the network’s informal nature, made up of a complex web of 
formal (coalitions, partnerships, etc.) and informal ties - it is hard to specify precisely 
when these ties crystallized into a network. Its existence, however, became evident in the 
months preceding the XIII International AIDS Conference held in Durban, South Africa 
(2000). This conference marks another turning-point in the debate over access to 
medicines; indeed, it is in Durban that the issue of patented drugs’ affordability was 
openly addressed for the first time in an international conference. By then, the existence 
of the AIDS TAN was clear; in fact, the AIDS TAN played an important role in drawing 
attention on this issue.
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Who ? Composition o f the AIDS TAN
“I honestly don't know what it means to be part of the AIDS activist community. If it 
means somebody who thinks the world hasn't paid enough importance to this, then
absolutely, I'm a full-fledged member.”
- Bill Gates, co-founder of the Bill and Melinda Gates Foundation
Activists would probably argue that it means somewhat more, but one thing is 
sure, the network is indeed incredibly dense and diverse, and to make a comprehensive 
list of the organizations participating in this network would prove a formidable task.
In Canada, for example, organizations involved in the issue of access to treatment 
include the Canadian Council for International Cooperation, the Canadian HTV/AIDS 
Legal Network, the Canadian Treatment Advocates Council (CTAC), Médecins Sans 
Frontières (MSP), Oxfam Canada, the Interagency Coalition on AIDS and Development 
(ICAD) and the International Council of AIDS Service Organizations (ICASO). Each of 
these organizations in turn has its own network: ICAD, for example, is a network of over 
120 Canadian international development NGOs, AIDS service organizations and 
individuals involved in global HTV/AIDS issues (ICAD 2002). The picture gets even 
more complicated with International NGOs such as MSP, which are also part of networks 
in each of the countries where they are active: in Kenya, for example, MSP is a member 
of The Kenyan Coalition on Access to Essential Medicines, a network of associations, 
PWAs, pharmacists, doctors, lawyers, journalists and other individuals advocating access 
to essential medicines in Kenya (MSP 2002).*^ Another example of the density and
The coalition includes among others the following organizations: Action Aid, PTDA, 
The Association of People living with AIDS in Kenya (TAPWAK), Network for 
people living with HIV/AIDS (NEPHAK),Women Fighting AIDS in Kenya 
(WOPAK), Society for Women and AIDS in Kenya (SWAK), Health Action 
International (HAI Africa), Nyumbani, Innovative Lawyering, International
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variety of organizations involved is the call for action “Lift the Barriers to Access to 
Treatment,” presented to the WTO Ministerial Meeting held in Seattle on 1 December 
1999.^
Let me stop here since the point is simply to give a sense of the AIDS TAN’s 
density and diversity. The AIDS TAN includes both organizations and individuals 
(journalists, doctors, lawyers, etc.). It includes first and third-world organizations at all 
levels, local, national and international. Although NGOs are the most dynamic force in 
the network, the latter also involves a number of inter-govemmental organizations, such 
as the WHO and the South Centre.
The network also includes different types of organizations: development and 
health organizations, such as Oxfam and Health Action International; humanitarian 
organizations, such as Médecins Sans Frontières; consumer groups (e.g. the Consumer 
Project on Technology/US); research groups (e.g. Third World Network); AIDS activists 
groups (e.g. ACT UP); grassroots organizations formed specifically around the issue of 
access to treatment (e.g. the Treatment Access Campaign/South Africa), as well as 
foundations (e.g. the Bill Gates Foundation) and faith-based groups, (see appendix I for a 
visual representation of the network). By providing a forum where individuals and 
groups could meet and exchange, international conferences played an important role in 
the formation of these networks (Keck and Sikkink 1998: 123).
Federation of Women Lawyers - Kenya (FIDA), Médecins sans Frontières (MSP), 
DACASA, Pharmaciens sans Frontières (PSF), Kenyan Medical Association (KMA) 
(MSF 2002).
The endorsement list of the call for action is available at: www.iglhrc.org. Accessed 
21 April 2002.
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What? Activists’ demands
“Health for all means that powerful interests have to be challenged, 
globalization has to be opposed, and that political and economic
priorities have to be drastically changed” 
- People’s Charter for Health (2000)^
In December 2000, community-based health groups, NGOs and civilians from 
over 90 countries met for the first People’s Health Assembly (PHA). The PHA explicitly 
positioned itself as a counterbalance to the WHA and as an alternative forum for the 
discussion of global health needs. As the above quote reveals, the PHA issued a strong 
call for action.
Not all participants in the network share the PHA’s position, but for the most part, 
there is, if not consensus, at least a remarkable uniformity in activists’ demands. While 
this seems surprising given the great variety of organizations involved in the network, it 
can be explained by the network’s pragmatic and single-issue orientation.
Organizations involved in the network are indeed committed to ensuring access to 
affordable and quality treatment for people with HTV/AIDS. They share the view that the 
fundamental cause of lack of access lies in the international trading system, including the 
nature of the pharmaceutical market and the way it is regulated. Given that health is a 
fundamental human right, activists argue that being denied access to health care for 
economic reasons is an infringement on human rights. Pointing to the discrepancy 
between the seriousness of the AIDS pandemic and the resources committed to fight it, 
activists demand a firm political commitment to mobilize the resources necessary to 
effectively address the pandemic. Concerning the issue of the affordability o f medicines
^  People’s Health Assembly 2000 People’s Charter for Health Available at: 
www.pha2000.org. Accessed 27 June 2002.
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itself, activists push for the adoption of a series of measures to ensure that medicines are 
affordable in developing countries. These include changes in international trade 
regulations, generic competition, differential pricing of drugs, pooled procurement of 
drugs, and technology transfers.
Activists recognize the need for a balance between IPRs and public health, 
provided that the protection of private profits does not take precedence over public 
health. To this end, they insist that developing countries must adopt TRIPS safeguards 
into their national legislation before the end of the transition period. These safeguards 
include compulsory licensing - the granting of a compulsory patent for the production or 
importation of lower-priced generic versions of patented products - and parallel 
importation, i.e. the importation of a branded drug sold at a lower price on another 
market. Activists also recognize, however, that encouraging generic competition is 
perhaps the most powerful lever for lowering drug prices. This can be achieved by 
relaxing IPRs laws and facilitating the use of compulsory licensing.
Activists call for a global policy for differential pricing that would take into 
account the huge gap in purchasing power between industrialized and developing 
countries. Under this system, drugs under patent would be sold at, or close to, cost price 
in developing countries, while higher prices in industrialized countries would ensure 
returns on the cost of R&D (Harrington 2000). Other mechanisms through which prices 
can be reduced include negotiated reductions for bulk purchase and pooled purchases by 
a number of small countries.
Activists also push for changes in US and other industrialized countries’ trade 
policy. The US have repeatedly used unilateral trade pressure to force developing
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countries to adopt stricter IPR protection than required under TRIPS (so-called “TRIPS- 
plus”)- Activists thus demand that the US stops pressuring countries not to adopt policies 
aimed at making essential drugs more available, and ceases efforts to incorporate IPR 
protection into new trade agreements (Weissman 2001).
These measures will have to be accompanied by re-investments in public health 
systems. Developing countries’ already weak public health systems have been hardly hit 
by structural adjustment policies and activists argue that it is necessary, if tri-therapy is to 
be made available on a large scale, to have well-funded, operational public health 
systems.
In the longer term, activists stress that research and development must be adapted 
to the needs of developing countries. This includes funding research for a vaccine, and 
developing new drug regimens and simplified diagnostic and monitoring tools.
Finally, encouraging local production is an essential component of any long term 
solution to the problem of access to medicines. Developing local manufacturing capacity 
would indeed reduce developing countries’ dependence on industrialized countries for 
their drug needs. It is a telling example that Brazil, one of the few countries that has 
successfully fought the epidemic by pursuing a policy of providing free ARVs to all 
people living with HIV/AIDS, has been able to do so in large part because of its domestic 
generic drug industry.
Of the 1393 new drugs approved between 1975 and 1999, less than 1 per cent (6) was 
specifically for tropical diseases (Trouiller and Olliaro 1999).
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How? Activists’ strategies
Activists resort to a vast array of sophisticated political strategies to achieve these 
objectives, from direct action to global petitions and lobbying. While some organizations 
favour conventional political action, others favour more unconventional strategies. But 
central to all these approaches is the strategic use of information (Keck and Sikkink 1998: 
2).
ACT UP is one example of an organization committed to confrontational politics 
and radical direct actions. It organizes boycotts, marches, demonstrations and nonviolent 
civil disobedience, and seeks to convey its message through symbolic politics (it is the 
author, for example, of the famous slogan “silence=death”). ^  ACT UP’s actions are 
organized in the French anarchist tradition of Taction exemplaire? whereas a 
spectacular, often theatrical, action calls people’s attention to the movement’s claims by 
playing on activists’ willingness to sacrifice (Castells 2001b: 106). In one of these 
actions, ACT UP members invaded the studio of the MacNeil/Lehrer NewsHour on 
January 22, 1991, chained themselves to Robert MacNeil’s desk during a live broadcast, 
and flashed signs saying “the AIDS crisis is not over” (Rimmerman 2002). While actions 
like those of ACT UP have obtained enormous media attention, they do not constitute the 
‘mainstream’ and are not unchallenged within the movement. A large segment of the 
AIDS TAN favours more traditional political actions, such as the petitioning and 
lobbying of governments, drug companies and international institutions.
The slogan, written on a black background with a pink triangle symbolizing 
homosexual persecution under the Nazis, was posted in public spaces in New York in 
1987 and was aimed at heightening awareness of the epidemic (Crimp 1991: 7).
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The AIDS TAN’s effectiveness stemmed in part from its ability to ‘reframe’ the 
issue of access to t r e a t m e n t . ‘Framing’ refers to “the conscious strategic efforts by 
groups of people to fashion shared understandings of the world and of themselves that 
legitimate and motivate collective action” (McAdam 1996: 6 in McCarthy 1997: 244). 
With regards to AIDS treatment, activists have succeeded in reframing the issue of access 
to HIV medications as a question of public health, human rights and global equity. This 
supports Keck and Sikkink’s (1998: 2) insight that “advocacy networks often reach 
beyond policy change to advocate and instigate changes in the institutional and principled 
basis of international interactions.” In Brazil, Columbia and Costa Rica, for example, 
activists have pressed government to recognize that access to HIV medications is a 
human right.
Framing is an extremely powerful device. Once access to treatment is viewed as 
a fundamental human right, the idea that there might be a double-standard of care and 
treatment in industrialized and developing countries becomes unacceptable and treatment 
can no longer be denied on grounds of cost-effectiveness and efficiency in the allocation 
of resources. Similarly, when the issue of access to treatment is seen as one of global 
inequity, attention shifts away from individual country’s policy to the international 
trading system. By reshaping our understanding of the nature and causes of the issue of 
access to treatment, activists modify our understanding of how the problem should be 
addressed.
More concretely, advocacy groups have played a variety of roles at the national 
level. Firstly, they have pressured governments to take action. In Brazil, for example.
For how the network’s effectiveness is measured, see the section “The AIDS TAN’s 
record after two years of existence” below.
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government officials acknowledge the role played by citizens’ groups such as Pela Vidda 
in pressuring the government to clarify its position on AIDS and adopt a policy of 
providing free ARVs to PWAs (Buckley 2000).
Besides ensuring that AIDS remains a top public health priority, advocacy groups 
actually help run programmes. Again in Brazil, some 600 NGOs are involved in the 
AIDS efforts, and the role of Brazil’s articulate and well-mobilized advocacy community 
in the success of the National AIDS Programme is widely acknowledged (Buckley 2000; 
Harrington 2000).
NGOs also play an important role as advisers to governments. Hence, at the 
request of the Thai government, MSF wrote a Report to the National AIDS Committee in 
which it reviewed the issue of access to AIDS treatment in Thailand, and made a series of 
recommendations as to how Thailand could improve access to medicines based on its 
options under the TRIPS Agreement (MSF 1999).
In industrialized countries, advocacy groups have also been able to influence 
policy. Recent changes in US policy, evidenced in Clinton’s Executive Order on access 
to HIV/AIDS pharmaceuticals and the decision not to be at the companies’ side in the 
South African trial, no doubt stem from the intense campaign led at home by US activists 
(Harrington 2000: 12; White House 2000).
Interestingly, NGOs have also taken part in legal proceeding. Hence, in the 
dispute opposing drug companies to the South African government, a South African 
NGO, Treatment Action Campaign (TAG), obtained the right to testify as a Friend of the 
Court.
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At the international level, advocacy groups have played the role of brokers 
between the various parties involved on the issue. At the Durban conference, for 
example, the US activist group ACT UP staged a private meeting of health ministers and 
AIDS activists (Nevill 2000). In doing so, advocacy groups have to some extent 
substituted themselves for multilateral agencies.
The strength of the advocacy effort, however, lies in international networking and 
global campaigns. In the next section, I examine in more detail one specific example, the 
global campaign surrounding drug companies’ decision to bring the South African 
government to court over South Africa’s 1997 Medicines Act.
The AIDS TAN in action: a case-study o f the South African campaign
In 1998, a consortium of 39 pharmaceutical companies, backed by the US 
government and the EU, filed a lawsuit against the South African government. 
According to the drug companies. South Africa’s 1997 Medicines Act represented a 
breach of South Africa’s IPR obligations under TRIPS.
In the wake of the demise of apartheid, a new Medicines and Related Substances 
Act (1997) was passed in an effort to make the public health system more equitable and 
accessible. It introduces four mechanisms to make medicines more affordable: the 
generic substitution of medicines no longer under patent; parallel importation-, 
international tendering for medicines in the public sector, and a pricing committee to set 
up transparent pricing mechanisms (TAG 2001). Drug companies argued that the Act 
gave too much power to the Minister of Health; more specifically, they claimed that 
generic substitution was a form of unfair discrimination, that parallel importation was not 
allowed under TRIPS, and that price controls interfered with their right to trade. As
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activists pointed out, however, both generic substitution and price controls are widely 
used in industrialized countries, and the TRIPS does not cover parallel importation 
(ibid.).^^
The AIDS TAN was quick to respond. A coalition including the South African 
TAC, ACT UP-Philadelphia, Oxfam America, Médecins Sans Frontières (MSP) and the 
Health GAP Coalition organized worldwide demonstrations. Activists led an intense 
media campaign to make their viewpoints known and MSP launched a global internet 
petition -  ‘Drop the case’ -  that gathered over 293,000 signatures. In an unprecedented 
decision, a South African NGO - TAC - obtained the right to testify as a Friend of the 
Court. By doing so, TAC was able to shift the focus of the trial from the drug 
companies’ emphasis on technicalities to the human rights dimension of the issue of 
access to drugs in the context of the AIDS epidemic (Sidley 2001: 635). It is interesting 
to see a national NGO testifying in support of its own government sued by a consortium 
of foreign companies.
The campaign was a success in all respects. The lawsuit provoked unprecedented 
outrage among the international community and, on April 18, 2001, i.e. three years after 
the beginning of the trial, drug companies announced that they would drop the case. 
Moreover, drug companies’ public image was so affected by the trial that some of them 
pledged significant price reductions.®^ These initiatives differed from earlier ones in that
Hence, the TRIPS Agreement “does not prohibit Members from applying the 
principle of international exhaustion -  that is, allowing parallel importation of 
patented pharmaceuticals once they have been placed on the market in any country” 
(Article 6) (WHO 2001).
Merck said it would offer two AIDS drugs (Crixivan and Stocrin) at cost, but only to 
certain sub-Saharan countries (Darlington 2001). Bristol-Myers Squibb, for its part, 
announced that it would offer its two AIDS drugs (Videx and Zerit) below cost.
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they represented more significant price reductions and were more extensive (although 
restrictions remained). Until then, the pharmaceutical industry had favoured a twofold 
strategy which consisted of funding charitable AIDS programmes and offering selective 
discounts and donations.M oreover, it was the first time that drug companies accepted 
to make public the cost of the drugs.’  ^ One drug company also made the highly unusual 
move of renouncing its patent for Zerit and announced that it would “ensure that its 
patents do not prevent inexpensive HTV/AIDS therapy in Africa” (Brystol-Myers Squibb 
2001). Finally, the Clinton administration also announced that it would stop pressing 
South Africa to change its law and that the US would not seek, through negotiation or 
otherwise, the revocation or revision of any intellectual property law or policy that 
regulates HIV/AIDS pharmaceuticals (White House 2000).
The optimism to which the outcome of the lawsuit gave rise was rapidly 
dampened, however, by South Africa’s announcement that it had no intention of offering 
free AIDS therapy to PWAs.^^ A new court challenge was launched, this time opposing 
TAC to the South African government. On July 5, 2002, the Constitutional Court -  the
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These initiatives were announced in 2000 as the industry attempted to deflect its 
growing public image crisis, and applied selectively to specific countries, drugs or 
even AIDS complications. Hence, Pfizer offered free Diflucan (fluconazole) to South 
Africans diagnosed with cryptococcal meningitis. The first significant price 
reduction was Glaxo-Wellcome’ s offer to reduce the price of Combivir from $16 per 
day in rich countries to $2 per day in selected poor countries (Harrington 2000). On 
11 May 2000, five leading companies signed an agreement with WHO and UN AIDS 
to reduce the price of antiretrovirals for developing countries, but this offer never 
materialized.
Hence, Bristol-Myers Squibb said that “the prices of products offered under the 
Access program would be made fully public” (Stolberg 2001).
Part of the explanation for this reversal is that, in the three years between the 
introduction of the South African Medicines Act and the court case, Thabo Mbeki 
replaced Nelson Mandela as President. Mbeki, who has stirred controversy by 
publicly denying that HIV causes AIDS, is known for his dubious positions on AIDS.
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highest South African judicial court -  ruled that people had a right to treatment and 
ordered the South African government to take measures to ensure access to treatment 
preventing mother-to-child transmission (Benkimoun 2002b).
The AIDS TAN’s record after two years o f existence
So what is the ADDS TAN’s record after two years of existence? While some 
limited progress has been made in broadening access to treatment, a global, long-term 
solution has yet to come, and AIDS drugs still remain out of reach of the vast majority of 
people who need them. But as Smith et al. (1997: 73) note, “few social movements are 
successful if by success is meant that they achieved specific policy changes.” There are 
other ways, however, by which social movements influence the outcomes of international 
political decisions, for example by focusing attention on a particular issue or by 
enhancing government accountability. By this standard, the AIDS TAN has been highly 
successful: indeed, it has succeeded in the space of less than two years in raising the issue 
of the affordability and accessibility of AIDS treatment from largely a ‘non-issue’ to a 
high profile and explosive one. In doing so, it has forced the pharmaceutical industry to 
make concessions, and governments to take action.
By creating a public image crisis for the pharmaceutical industry, the network 
succeeded in pressuring drug companies to lower drug prices. Between August 2000 and 
August 2001, the price of AIDS tri-therapy fell from US$10,000 per patient per year 
(brand) to as low as US$350 (generic) (Hoen and Moon 2002). Of course, the extent to 
which this can be attributed to activists - as opposed to deeper structural causes - remains 
open to debate. Price reductions, however, were an attempt to redeem drug companies’
The text of the Court Judgment is available at: www.tac.org.za.
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image in the eye of the public, and it is clear that both activist pressure and increased 
generic competition played a role in prompting reductions in drug prices.
The AIDS TAN has also prompted concrete policy changes. In South Africa, as 
we have seen, the campaign led pharmaceutical companies to drop their lawsuit against 
the South African government’s Medicine Act. Pressure by the activist community also 
forced the US to change its trade policy. In Thailand, the US government announced in 
January 2000, under pressure from NGOs and the international community, that it would 
stop using unilateral trade pressure in retaliation for the Thai government’s use of 
compulsory licensing (MSP 2000). In Brazil, the US withdrew its complaint before the 
WTO regarding the right of the Brazilian government to issue compulsory licenses (June
2001) (Raghavan 2001a). More significantly, Clinton, in the wake of the South African 
trial, issued an executive order stating “that the US shall not seek, through negotiation or 
otherwise, the revocation or revision of any intellectual property law or policy [...] that 
regulates HTV/AIDS pharmaceuticals or medical technologies” (White House 2000). 
While these announcements have generally been hailed as a “real policy shift,” some 
observers have questioned whether they are not rather motivated by public relations 
considerations (Chaudhry 2000).
At the international level, activists succeeded in making the WTO recognize the 
primacy of public health over IPRs and reassert countries’ right to take all measures 
deemed necessary for the protection of public health. At the WTO Ministerial 
Conference held in Doha (November 2001), a ‘Declaration on the TRIPS Agreement and 
Public Health’ was adopted. It states that ‘the TRIPS Agreement does not and should not 
prevent members from taking measures to protect public health,’ and ‘should be
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interpreted and implemented in a manner supportive of WTO members’ right to protect 
public health and, in particular, to promote access to medicines for all’ (Hoen and Moon
2002).^
Most importantly perhaps, the AIDS TAN succeeded in reframing the debate in 
terms of public health, human rights and global equity. While the sheer gravity of the 
AIDS crisis no doubt goes part of the way in explaining this shift, advocacy groups also 
played an important part. As Keck and Sikkink (1998: 2) argue, TANs “try not only to 
influence policy outcomes, but to transform the terms and nature of the debate”. This in 
turn played a significant role in prompting a paradigm shift from prevention to treatment. 
While AIDS efforts in developing countries until recently focused exclusively on 
prevention -  treatment being deemed not ‘cost-effective’ in resource-poor settings -  
activists have forced the recognition, not only that treatment is an essential component of 
any effective prevention strategy, but that treatment cannot be denied on economic 
grounds.
Despite the fact that the issue of access to treatment has now achieved a high 
profile, there still is a lack of mobilization and commitment. Hence, the Global Fund to 
Fight AIDS, Tuberculosis and Malaria, created in April 2001, remains severely under­
funded.^^ We must keep in mind, however, that two years is a very short time frame, 
especially when we think that treatment was discovered in 1996 and that the issue of
^  The text of the Declaration is available at: www.wto.org. Accessed June 24, 2002. 
For an interpretation, see ‘Overview of the Benefits of the Doha Agreement on 
TRIPS and Public Health.’ Available at www.cptech.org. Accessed 1 December 
2001.
^  To date, pledges to the Global Fund from government and private contributions 
amount to roughly $2 billion, of which the US has pledged $500 million. This is a far 
cry from the $9 billion needed annually for the Global Fund to be fully operational. 
See the Fund’s homepage at www.globalfundatm.org.
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access to treatment was largely a ‘non-issue’ only two years ago. While it is too early to 
draw any definite conclusions as to the network’s effectiveness, it is not exaggerated to 
say that its record to date is impressive.
The AIDS TAN: A Contemporary Example o f the Double Movement?
Before going any further, let me restate briefly what Polanyi meant by the notions 
of double movement and social protection. In The Great Transformation, Polanyi argues 
that “for a century, the dynamics of modem society was governed by a double 
movement,” whereby “the market expanded continuously, but this movement was met by 
a countermovement checking the expansion in definite directions” (Polanyi 1957: 130). 
More concretely, the concept of double movement is conceived “as the action of two 
organizing principles in society, each setting itself specific institutional aims, having the 
support of definite social forces and using its own distinctive methods” (ibid.: 132).
As we have seen in chapter two, the principle of economic liberalism aims at the 
establishment of a self-regulating market, it relies on the support of the trading classes 
and uses largely laissez-faire and free trade as its methods. The principle of social 
protection, for its part, aims at the conservation of man and nature as well as productive 
organization; it relies on the support of those most immediately affected by the 
detrimental action of the market, and it uses protective legislation, restrictive 
associations, and other instmments of intervention as its methods (ibid.: 132). In this 
section, 1 discuss the AIDS TAN with regards to Polanyi’s three criteria of social 
protection: aim, membership and methods.
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The AIDS TAN and social protection
Aim
According to Polanyi (1957: 215), the general purpose of social protection is “to
rehabilitate the lives of men and their environment, to give them some security and
status.” The AIDS TAN shares similar aims, as it tries to counter the social disruption
wrought by AIDS in a context of economic liberalization and lack of access to treatment.
This appears very clearly in activist organizations’ mandates and statements: as the South
Centre (2001) wrote in the context of the ‘Drop the case’ petition, the objective is “to
reinstate the primacy of human values and human life itself.”
What Polanyi criticizes is not the market itself, but the attempt to establish a ‘free’
market. Put differently. The Great Transformation is not so much a critique of the
market economy - the organization of the economy on a market basis -  as a critique of the
market society, i.e. the extension of the market to areas that are not exclusively, or not
primarily, economic. This offers an interesting parallel with the AIDS TAN, since what
AIDS advocates criticize is not capitalism, nor globalization (understood as the expansion
of international exchanges), but neoliberalism, characterized by the accelerating
concentration and penetration of corporate capital, and its institutionalization into a new
international legal framework (Starr 2000: 25).
Nowhere is this made clearer than in the Global Manifesto “Access to Treatment
for All... Now!,” issued at the 2000 AIDS Conference held in Durban, South Africa.
Speaking to the IFPMA, the authors write:
“The pricing policy defended by the International Federation of Pharmaceutical 
Manufacturers' Association (IFPMA), where patent monopolies allow your members 
to place essential drugs beyond the influence o f market competition, has become the 
cause of an unprecedented burden of illness and death. We do not dispute your need
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to recover investments in research and development, or to profit from these 
investments. But, in your hands, the profit motive has led to the development of new 
medicines that are far out of reach of the people who need them” (Global Manifesto 
2000; my emphasis).
This excerpt shows that activists do not reject the market economy. At one level, 
what activists deplore is not that there is too much market competition, but that there is 
not enough. Indeed, in a striking, though not surprising, contradiction, the liberalization 
of health care has been accompanied by a rise in multinational corporations’ market 
power (as we have seen in chapter two, their monopoly powers are being expanded 
through both consolidation in the industry and the strengthening of IPRs). As for the 
profit motive, activists are critical of it only to the extent that it overrides considerations 
of human well-being and public health. Epstein (1997: 433) notes how AIDS activism is 
unusual in the extent to which its activists depend upon the energy and good will of their 
own interlocutors; in other words, the extent to which they are ultimately dependent upon 
the biomedical enterprise for the discovery and testing of treatments. Significantly, 
solutions put forward by activists - whether generic competition, international tendering 
of medicines, parallel importation, compulsory licensing or pooled procurement and bulk 
purchases of drugs - are market-based.
Similarly, and this is an important distinction, most activists involved in the AIDS 
TAN do not oppose economic globalization per se, but rather the conditions under which 
it is taking place, as embodied in the emerging global trade system. A common 
complaint is that “the emerging global trade system [...] treats medicines like all other 
products” (MSP 2002). As Castells (2001b: 108) notes, “the new social movements, in 
their diversity, react against globalization, and against its political agents.” In this case, 
the global trade system is embodied by international financial and trade institutions (IFIs,
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the WTO), the pharmaceutical industry, and those industrialized countries with a strong 
pharmaceutical industry (the US, the EU, Japan and Canada).^
In Castells’ (2001b: 69) terminology, the AIDS TAN is not reactive, a form of 
identity-based mobilization, but proactive, i.e. purveyor of a social project. Despite 
variations in emphasis, the individuals and organizations working around the issue of 
access to treatment clearly share the vision of a social order where human lives and well­
being take precedence over economic considerations, and where life-saving treatment 
cannot be denied on grounds of cost-effectiveness.
If the aim of social protection has remained the same, it is because capitalism’s 
underlying logic itself has not changed. While nineteenth century and late twentieth 
century liberalism represent different phases of capitalist development, the logic driving 
this development -  the continued expansion of the market economy - has remained the 
same. Hence, while nineteenth century liberalism aimed at the commodification of 
labour and land, the current phase of liberalization aims at the commodification of life 
forms (e.g. the patenting of genes, seeds and plants), knowledge (e.g. indigenous 
knowledge) and, in the case in point, public services including health, all elements that 
were until recently considered public goods or part of the commons.
Participation
In The Great Transformation, Polanyi makes the obvious point that social 
protection relies on the support of those most immediately affected by the detrimental
^  The Global Manifesto (2000), for example, is addressed “to the governments of the 
USA and European Union,” “to the International Federation of Pharmaceutical 
Manufacturers’ Association” and “to the International Bureaucracies of UN AIDS and 
the WHO. ”
100
impact of the market. In the context of nineteenth century industrialization, this was 
primarily, but not exclusively, the working and landed classes.^ This is verified in the 
case under consideration by the fact that PWAs have played -  and continue to play - a 
determining role in AIDS advocacy. Their role was officially recognized at the 1994 
Paris AIDS Summit with the adoption of the ‘GIPA Initiative’ (Initiative for the greater 
involvement of people with AIDS).^* While early AIDS activists were often HIV- 
positive themselves,^ the movement subsequently diversified to include many 
seronegative activists (Wachter 1992). It remains true, however, that most people 
involved in the network are directly or indirectly affected by HTV/AIDS.
More importantly, while those most directly affected by the market are still the 
driving force behind the movement for social protection, this group, as a result of 
globalization, now cuts across borders and classes. AIDS is unique in its ability to create 
new networks among people regardless of their geographical and social milieu, as 
reflected in the fact that participation in the AIDS TAN transcends identity and ideology. 
The network indeed draws together North American AIDS activists and members of 
Southern associations of PWAs along with researchers, physicians and members of 
international organizations.
Although some Southern NGOs, for example the South African TAC, have 
become quite vocal. Southern associations and activists generally rely on the technical
^  In contrast to Marx, Polanyi did not confer a key role to the intelligentsia and did not
conceive of the working class as the only truly progressive force in society. 
On the rc 
348-356.
ole of PWAs in the AIDS movement, see Mann and Tarantola (1996), pp.
^  In addition to PWAs’ obvious stakes in the issue (after all, treatment means life), this 
can also be explained by the stigma associated (still associated in some parts of the 
world) with AIDS in the early years of the epidemic.
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and financial support of Northern NGOs and on their networks and connections to make 
their voices heard abroad and gain access to international actors. Northern NGOs in turn 
need southern NGOs to establish their credibility and legitimate their claim that they 
speak on behalf of PWAs in the developing world. While they mutually stand to benefit 
from their collaboration, northern NGOs often have more power than their southern 
counterparts, a situation which can create tensions.
Methods
In contrast to the dominant Marxist interpretation, and long before NSM theorists, 
Polanyi recognized that social movements were no longer necessarily aimed at seizing 
state power. Instead, Polanyi understands resistance as countermovements arising under 
varied forms and from different sectors of society. Hence, in nineteenth century Great- 
Britain, the principle of social protection took a variety of forms: it was not limited to the 
working-class, nor was it necessarily progressive. Social protection was embodied in 
factory legislation, social insurance, health services, public utilities and labour unions, 
but also took the form of cartels and trusts, and of embargoes on immigration (Polanyi 
1957:144^
The contemporary AIDS TAN, of course, relies on very different methods. As we 
have seen in the case of the South African campaign, the strategic use of information and 
the employment of sophisticated political strategies in targeting campaigns are central to 
the operation of TANs (Keck and Sikkink 1998: 2). Moreover, TANs operate largely 
independently of governments. Organizations such as Médecins Sans Frontières, for 
example, rely on private donations for 79 per cent of their income (MSP 2000/2001: 86). 
This is in sharp contrast to nineteenth century society, where social protection mostly
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took the form of government intervention (e.g. social legislation, social services etc.). As 
Polanyi writes, the “vital need for social protection [...] commonly falls to the person in 
charge of the general interests of the community -  under modem conditions, the 
government o f the day” (1957: 154; my emphasis). The AIDS TAN’s relationship to 
governments, in contrast, is much more complex, and involves pressure and lobbying, 
partnership and open confrontation. Hence, in South Africa, as we have seen, activists 
supported the South African government in the court case opposing it to pharmaceutical 
companies, but later themselves brought the government to court to challenge its decision 
not to provide free ARVs to prevent mother-to-child transmission.
Limitations of Polanyi’s theory
As mentioned earlier, one obvious weakness of Polanyi’s theory is the vague and 
ambiguous way in which the term ‘society’ is used. The focus on ‘society’ obscures the 
complex dynamics within society. It ignores, for example, the different ways in which 
various sectors of society are affected by, and respond to, liberal economic policies. 
Moreover, the focus on society prevents us from looking at contradictory trends within 
the principle of social protection, for example disagreements among activists on priorities 
or strategies, or differences in power or influence within the network (for example 
between northern and southern NGOs). While this critique is not without value, it is 
explained in part by the fact that Polanyi’s theory is a macro-theory that aims at 
explaining the dynamics of economic liberalism and social protection, and not an in- 
depth analysis of particular social movements.
Some have seen in this ambiguous definition of society the source of Polanyi’s 
‘underdeveloped sense of agency’ (Birchfield 1999: 39). Indeed, another problematic
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dimension of Polanyi’s theory is that the principle of social protection is conceived as 
being spontaneous. Hence, Polanyi writes that “18*^  century society unconsciously 
resisted any attempt at making it a mere appendage of the market” (1957; 77; my 
emphasis). While this assertion is open to debate with regards to nineteenth century 
society, it certainly does not apply to AIDS advocacy. Indeed, AIDS activists are 
consciously resisting the extension of the free-market to certain spheres of human 
activities and are acutely aware of the purpose and targets of their actions.
The principle of social protection is also conceived by Polanyi in reactive terms. 
Hence, the “countermovement” is described as “more than the usual defensive behaviour 
of a society faced with change, [...] a reaction against a dislocation which attacked the 
fabric of society” (Polanyi 1957: 130; my emphasis). It can also be argued, however, that 
it is social struggles that drive the reform and restmcturing of the institutions of capital, 
so that globalization would in fact be a response to the social struggles of the nineteenth 
and twentieth century (Hardt and Negri 2001: 51). Moreover, insofar as they are 
purveyors of social projects, stmggles bear not only negative forces but also positive 
ones, even when they are antisystemic (ibid.: 61).
The ‘new quality ' o f social movements
To conclude that the AIDS TAN illustrates Polanyi’s principle of double 
movement is not to say that there is nothing new under the sun. Contemporary social 
movements have indeed developed new forms of action in response to changing 
conditions, leading some observers to emphasize the ‘new quality’ of social movements 
(Hardt and Negri 2001: 56). This section takes up and develops four outstanding
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characteristics of the AIDS TAN: the biopolitical nature of its struggle, the centrality of 
knowledge and information, its network form of organization and its transnational scale.
Biopolitics
NSM theorists have emphasized the cultural nature of new social movements, to 
distinguish them from the explicitly political economic objectives of working-class 
movements. More recently, some have pointed out that the cultural and the economic 
cannot be so neatly divided, and that these movements in fact address political economic 
issues (Adam 1993). These struggles can perhaps best be conceived as ‘biopolitical,’ that 
is struggles that cannot be neatly labelled as economic, political or cultural, but are 
struggles over the very forms of life (Hardt and Negri 2001: 56).
The term ‘biopolitics’ was developed by Foucault to address the relation between 
the human body and institutions of power. As Foucault writes, “the control of society 
over individuals is not conducted only through consciousness or ideology, but also in the 
body and with the body” (Hardt and Negri 2001: 27). It is with the growth of scientific 
knowledge about the human body in the eighteenth century that life entered the realm of 
politics (Foucault 1990: 143). Indeed, humans for the first time had the power to control 
and modify life processes. According to Foucault, biopolitics is inseparable from the rise 
of capitalism: as economics assumed growing importance for the state, the latter sought 
ways to ensure its population’s productivity (Foucault 2000: 73). This was achieved 
through ‘biopower,’ i.e. the technologies used by diverse institutions (the police and the 
army, but also the family and schools) to produce ‘docile’ (i.e. productive) subjects.
This was evidenced in the development of an array of disciplines, from housing to 
public health and migration.
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Hardt and Negri (2001) argue that we are now in the presence of a new regime of 
biopower, which concerns not only production, but also reproduction. In this new 
biopolitical economic and institutional system, power reaches more deeply into the social 
body: “the new power lies in the codes of information and in the images of representation 
around which societies organize their institutions, and people build their lives, and decide 
their behavior. The sites of this power are people’s minds” (Castells 2001b: 359).
If Hardt and Negri are right in positing the transition to a new regime of 
biopolitical production, then it should come as no surprise that contemporary social 
movements embrace biopolitical objectives. The AIDS TAN is the paramount example 
of the biopolitical quality of new social movements: indeed, it is concerned with the 
political-economic implications of the new order for health and human well-being, i.e. for 
life itself.
Centrality o f information & knowledge
If the new sites of power are people’s minds, then it is not surprising that 
information and knowledge have come to occupy a central place in economy and society, 
as revealed in talks of an ‘information age,’ an ‘informational economy,’ or of an 
‘information technology paradigm’ (Castells 2001a; Plihon 2001). The new information 
and communication technologies -  for example the Internet and new telecommunications 
and software technologies - have been hailed as the third industrial revolution, one in 
which “the productivity and competitiveness of units or agents in [the] economy 
fundamentally depend on their capacity to generate, process, and apply efficiently 
knowledge-based information” (Castells 2001a: 77).
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As we have seen, information and new technologies also occupy a central role in 
transnational AIDS advocacy. As Castells (2001b; 106) argues, “the powerful impact of 
each of these movements has come, to a large extent, from their media presence and from 
their effective use of information technology.”
If the new centrality of information and knowledge is widely acknowledged, the 
implications of the development of new information technologies are not clear. The latter 
are indeed characterized by both democratization (through horizontal and de­
territorialized device like the Internet), and centralized production, mass distribution and 
one-way communication in communication systems dominated by a small number of 
corporations (like the broadcast system and the printed media) (Hardt and Negri 2001: 
298). The AIDS TAN, which relies importantly on symbolic politics, the Internet, and 
the strategic use of information, illustrates the prospects of new information technologies 
for developing new political processes.
Network form o f organization
Another characteristic of NSMs exemplified by the AIDS TAN is their 
organization in n e tw o rk s.A cco rd in g  to Castells (2001b: 359), this horizontal, flexible 
form of organization and intervention is a response to the fact that power is becoming 
more diffused: “power [...] is no longer concentrated in institutions (the state), 
organizations (capitalist firms) or symbolic controllers (corporate media, churches). It is 
diffused in global networks of wealth, power, information and images.”
It is interesting to note that the organization of advocacy in the form of transnational 
networks parallels the organization of production in transnational networks made up 
of various components, and the shift from commodity markets to service networks 
(Castells 2001a; Rifkin 2000).
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The network form of organization is well-adapted to the geographically dispersed 
nature of the communities represented by the movement, as well as to the centrality of 
information to their operation. As we have seen, these networks do more than share and 
distribute information; they also produce information and (re)frame existing 
understandings. As Castells (2001b: 362) notes, “it is this decentered, subtle character of 
networks of social change that makes it so difficult to perceive, and identify, new identity 
projects coming into being.” Yet, as we have seen, the AIDS TAN is not reactive, a form 
of identity-based mobilization, but proactive, i.e. purveyor of a social project.
Transnational scale
In an article on social movements and global capitalism. Ski air (1999: 291) argues 
that “although capitalism is increasingly organized on a global basis, effective opposition 
to capitalist practices tends to be manifest locally.” Mobilization around the issue of 
access to treatment, however, belies this conclusion. Indeed, one important new aspect of 
AIDS treatment advocacy is its organization on a transnational scale.
By ‘transnational,’ I refer to the fact that the AIDS TAN is a worldwide network 
that links organizations across borders. Transnational networks include transnational 
organizations (i.e. organizations that operate in more than two countries), but also 
national and local ones. The development of a TSM sector is a recent phenomenon - the 
vast majority of transnational social movement organizations (TSMOs) emerged in the 
latter half of the twentieth century - and this sector has undergone dramatic growth in 
recent years (Keck and Sikkink 1998: 10; Smith 1997: 46).'°^
More than 60 per cent of all TSMOs active in 1993 were formed after 1970 (Smith 
1997: 46).
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If, as we have seen in chapter two, the network society is characterized by a 
fundamental opposition between two spatial logics, that of the space of flows and that of 
the space of places, the organization of advocacy networks on a transnational scale can be 
interpreted as reflecting the attempt to bridge this divide and organize on a scale 
commensurable to the forces at play. In sum, the AIDS TAN is not prone to 
‘localization’ as a response to globalization. On the contrary, activists insist that 
solutions to the problem of access to treatment are to be found at the global level.
From ‘global health rights’ to ‘therapeutic citizenship implications o f this new form o f 
advocacy
The AIDS TAN is witness to the emergence of new forms of social solidarity 
other than the territorially-defined nationality (Jacobson 200T. 162). ‘Biosociality,’ for 
example, refers to the organization of transnational social communities around a 
biological category, for example seropositivity'°^ (Nguyen 2001: 310). What are the 
implications of this new form of advocacy - for example ideas of ‘global health rights’ 
and ‘therapeutic citizenship’ - for the way in which we conceive of citizenship?
We have seen how TANs are among the most important sources of new ideas, 
norms and identities (Keck and Sikkink 1998: x). This is certainly verified in the case of 
the AIDS TAN: the latter has put forward novel ideas, such as that of global health rights, 
and sought to substitute health equity to the market logic as the norm for the provision of 
medicines. Moreover, there is no doubt that the identities of those involved in these 
networks are being transformed in the process of their transnational activities, as 
witnessed by the emergence of the notion of therapeutic citizenship.
103 Testing positive for antibodies to HIV.
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Transnational AIDS advocacy is thus an example of a ‘constituent struggle,’ i.e. 
one that creates new public spaces and new communities (Hardt and Negri 2001: 56). 
One example of such communities are ‘epistemic communities’ i.e. “transnational 
networks of knowledge-based communities that are both politically empowered through 
their claims to exercise authoritative knowledge and motivated by shared causes and 
principled beliefs” (Haas, in Keck and Sikkink 1998: 125). The AIDS TAN also fosters 
new transnational identities, such as the idea of ‘therapeutic citizenship.’ Health-related 
activism has indeed led to the formation of groups that “constmct identities around 
particular disease categories and assert political claims on the basis of those new 
identities” (Epstein 1995). Hence, in the gap between the official response to the 
pandemic and the growing awareness of its socio-economic roots, AIDS advocates have 
put forward the idea of ‘global health rights,’ i.e. that people are entitled to certain 
minimum standards of care and treatment, irrespective of their citizenship. This is a 
striking example of “how the logic of rights is at least complementing, and increasingly 
constraining, the logic of popular sovereignty” (Jacobson 2001: 162).
Most significantly, by defending the idea that health is a fundamental human 
right, the transnational AIDS coalition illustrates Bull’s claim that “the doctrine of human 
rights [...] is subversive of the whole principle that mankind should be organized as a 
society of sovereign states,” since it rests on the idea that “the rights of each man can be 
asserted on the world political stage over and against the claims of his state” (Bull, 
quoted in Keck and Sikkink 1998: 209). The doctrine of state sovereignty stipulates that 
the state “is subject to no other state, and has full and exclusive powers within its 
jurisdiction” (Hoffmann, quoted in Keck and Sikkink 1998: 36). Transnational network
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activity, however, presumes precisely the contrary: that it is legitimate for states or non­
state actors to be concerned about how citizens of another state are being treated (Keck 
and Sikkink 1998: 36). The way in which transnational networks reach beyond borders 
thus undermines sovereignty by blurring the lines between a state’s relation to its citizens 
and the recourse of individuals and states to the international system (ibid.: 1).*^
Transnational AIDS advocacy clearly fills a gap created by the weakening of the 
UN system and by states’ inability (or unwillingness) to respond to some of the 
challenges posed by globalization. Once more. South Africa is an excellent case in point: 
during the three-year court challenge, the WHO and the UN did not come out publicly in 
support of the South African government (Raghavan 2001a). As the case gathered 
momentum, however, the WHO announced that it would support South Africa and 
provide legal council to the South African government. The WHO spokesperson justified 
WHO’s involvement by stating that the 1997 South African law respected TRIPS and 
that WHO would “do anything possible within the TRIPS Agreement to get prices down” 
(de la Vaissière 2001). A few days later, however, WHO retracted its statement of 
support for the South African government, reiterating that it had a general policy not to 
take position in litigation in member states (Associated Press 2001). In the context of 
UN’s inaction, the AIDS TAN played a determining role in influencing the outcome of 
the trial.
This is not to say that the state has become obsolete. But while activists still rely 
importantly on states to achieve their objectives, the state is no longer the sole (nor is it
In the boomerang effect characteristic of TANs, for example, “domestic NGOs 
bypass their state and directly search out international allies to try to bring pressure on 
their state from outside (Keck and Sikkink 1998: 13).
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necessarily the principal) target of action. This is because its role has changed from agent 
of progressive change to provider of greater access to capital for the domestic economy. 
This does not mean, however, that the state has become irrelevant. Hence, while the 
TRIPS Agreement is a step towards universal standards of IPRs, there is no such thing as 
an international patent yet. As this discussion shows, however, the networking logic of 
transnational advocacy and the formation of new transnational identities and communities 
contribute to undermine the basis of the nation-states’ legitimacy and authority.
What are the AIDS TAN’s prospects for finding sustainable solutions to the issue 
of lack of access to medicines in developing countries, and for bringing about social 
change more generally? Does the AIDS TAN pose a genuine challenge to neoliberal 
globalization or is it likely to lead to some form of ‘embedded neoliberalism’? Keeping 
in mind a limitation of this study -  its lack of hindsight -  I would like to conclude by 
offering some thoughts on the prospects of treatment advocacy in the short, medium and 
long term.
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CONCLUSION
Transnational AIDS Advocacy: What Lies Ahead?
“Liberal economic rules have become 
incompatible with the globalization of the AIDS epidemic.
What is required is a new pact between industry and society”
- Peter Piot, Director, WHO'°^
AIDS treatment advocacy clearly reflects the stmggle to define a place for social 
concerns threatened by the increasing emphasis on liberalization. To the extent that it has 
succeeded in forcing the market to accommodate concerns over accessibility to treatment, 
the AIDS TAN supports Polanyi’s argument about the capacity of societies to shape 
economic institutions in accordance to their social priorities.
The AIDS TAN illustrates the idea of a double movement of social protection 
against the expansion of market forces to fundamental areas of social life. Indeed, it 
clearly meets the (admittedly broad) definition of social protection as encompassing 
“openly declared demands on the national, transnational and global levels for protective 
measures against [...] the implementation and expansion of the self-regulating market” 
(Mittelman 2000: 171).
Whether in terms of funding, effectiveness or credibility, the AIDS TAN has 
become a force to be reckoned with. AIDS activists have succeeded in reframing the 
debate in terms of public health, human rights and global equity. Witness to their success 
is the growing recognition, not only among activists but also among developing 
countries’ governments, multilateral institutions and the scientific community, that the 
roots of the problem of access to AIDS drugs are ultimately structural. In the words of 
Dr. Gro Brundtland, Director General of the WHO, lack of access to AIDS therapy
Quoted in Libération, 5 March 2001; my translation.
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amounts to “a problem of credibility for the global market system” (Associated Press 
2000).
Despite the fact that only limited progress has been made in broadening access to 
treatment, the network has succeeded in raising the profile of the question of affordability 
and accessibility. The sharp drop in the price of AIDS drugs results, at least in part, from 
activists’ campaigns and the ensuing public image crisis for the drug industry. On the 
policy front, the network has won specific campaigns at the national level (for example in 
South Africa and in Brazil), and influenced developments at the international level, as 
evidenced by the Doha Declaration on the TRIPS Agreement and Public Health.
While the paradigm shift from prevention to treatment attests to the power of 
TSMs to bring about social change, the prospects of finding sustainable solutions to the 
issue of lack of access to AIDS medicines in developing countries remain uncertain at 
this writing. What is clear, however, is that AIDS advocates working in networks have 
developed innovative ways to force international attention to the issue of lack of access to 
AIDS treatment in the South and to make their claims heard.
The AIDS TAN is characterized by a loose, but structured, form of organization, 
and by the fact that it is single issue-oriented. Most significantly, it goes beyond the state 
in search of transnational or global solutions. This refutes the commonly-held view that 
social movements ‘command place better than space,’ as well as the assumption that 
identities are rooted in place. This view is summed up by Harvey (1990: 302), who 
writes that:
“The capacity of most social movements to command place better than space puts a 
strong emphasis upon the connection between place and social identity. [...] The 
consequent dilemmas of socialist or working-class movements in the face of 
universalizing capitalism are shared by other oppositional movements -  racial
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minorities, colonized peoples, women, etc. -  who are relatively empowered to 
organize in place but disempowered to organize over space. In clinging, often out if 
necessity, to a place-bound identity, however, such oppositional movements become 
a part of the very fragmentation which a mobile capitalism and flexible accumulation 
can feed upon.”
The development of transnational forms of advocacy such as the network around 
access to treatment thus represents a significant development. Indeed, new identities 
formed by activists in the AIDS TAN are not ‘place-bound,’ but linked to a therapeutic 
condition (as in the case of ‘therapeutic citizenship’), or social commitment (for example 
to more equitable access to medicines). Moreover, treatment activists have found 
effective ways, by using new information technologies like the Internet, to organize over 
space. This ‘transnationalization’ of social movements parallels the global expansion of 
market forces.
Approaching transnational AIDS advocacy in a Polanyi an manner, i.e. as an 
attempt to re-embed the economy (or health) in society, proves valuable, firstly, because 
it draws attention to the fundamental tension between market and social protection, and 
away from the state and conventional politics towards a broader understanding of 
resistance as counter-movements ; and secondly, because it focuses attention on de­
commodification (or re-embedding) as what is centrally at stake.
Indeed, in the long term, what is ultimately at stake, beyond access to life-saving 
treatment, is the commodification of health. The AIDS pandemic is now forcing a 
growing recognition that lack of access to AIDS therapy amounts to a giant market
Of course, this raises the issue of what is driving what. Have social movements 
become transnational to match a globalizing capital? Or, as Hardt and Negri argue, is 
the globalization of capital a response to social movements? According to the latter, 
“international cycles of struggle were the real motor that drove the development of 
the institutions of capital and that drove it into a process reform and restructuring” 
(Hardt 2001: 51).
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failure. This failure of the globalized market economy to meet health needs, particularly 
blatant with regard to AIDS, challenges the earlier assumption that health needs are 
“commodities that can be profitably supplied by capitalist enterprises like the drug 
industry” (Lexchin 1984: 210).
This recognition has led activists to question the appropriateness of leaving health 
up to the vagaries of the free market. The crucial question, then, is “what does it mean to 
‘re-embed’ health care in society?” While the dominant interpretation of Polanyi’s re­
embeddedness thesis is that protective social measures -  as, for example, under the 
welfare state -  represent the reassertion of social control over the market. Lâcher (1999b) 
- and 1 am sympathetic to this view - argues that protectionism falls short of reasserting 
social control over the market: only with de-commodification can the economy be 
genuinely re-embedded. According to Lâcher, it is precisely because the economy was 
only partially re-embedded in the post-World War period that we saw, starting in the 
early 1980s, the resurgence of neoliberalism and the concomitant demise of the welfare 
state.
What activists reject, it bears repeating, is not globalization itself, but specific 
dimensions of this broad and multidimensional process, such as the neoliberal push to 
commodify health. Activists do not seek to delink from either the state or the market. If 
we understand the commodification of health as the reliance on the market for the 
financing and delivery of health care, treatment activists seek to reassert social control 
over the market, but not to de-commodify health. Indeed, as we have seen, activists’ 
solutions to market failure with regards to access to AIDS treatment -  for example, 
generic competition, the international tendering of medicines, parallel importation.
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compulsory licensing or pooled procurement -  are market-based mechanisms, and thus 
do not delink from the market for the production and distribution of medicines.
If we follow Polanyi’s argument through to the end, this is far from trivial. 
Polanyi indeed argued that protectionism could successfully protect society against the 
detrimental consequences of the market, but that, as long as the market remained the 
basic organizing principle, interference with the market mechanism could only 
exacerbate the contradiction between economy and society, creating strains and tensions 
that eventually culminated in crises.
What lies ahead is open to speculation. In applying a Polnayian approach to 
contemporary developments, however, it is important to keep in mind Lâcher’s (1999b) 
warning against the temptation of simply projecting the double movement into the future. 
After all, it was another of Polanyi’s fundamental insight that history should not be 
conceived in a teleological fashion: "The future,” Polanyi writes, “is constantly being 
remade by those who live in the present.”
Polanyi (1920); unpublished manuscript, quoted in Polanyi-Levitt (1990: 118).
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